1,055 results on '"Chioncel, Ovidiu"'
Number of results to display per page
Search Results
52. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial
- Author
-
Tomasoni, Daniela, primary, Davison, Beth, additional, Adamo, Marianna, additional, Pagnesi, Matteo, additional, Celutkiene, Jelena, additional, Chioncel, Ovidiu, additional, Cohen-Solal, Alain, additional, Filippatos, Gerasimos, additional, Ponikowski, Piotr, additional, Sliwa, Karen, additional, Cotter, Gad, additional, and Metra, Marco, additional
- Published
- 2024
- Full Text
- View/download PDF
53. Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)
- Author
-
Vaduganathan, Muthiah, Dei Cas, Alessandra, Mentz, Robert J, Greene, Stephen J, Khan, Sadiya, Subacius, Haris P, Chioncel, Ovidiu, Maggioni, Aldo P, Konstam, Marvin A, Senni, Michele, Fonarow, Gregg C, Butler, Javed, Gheorghiade, Mihai, and Investigators, EVEREST Trial
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Cardiovascular ,Diabetes ,Heart Disease ,Kidney Disease ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Aged ,Comorbidity ,Diabetes Mellitus ,Dose-Response Relationship ,Drug ,Double-Blind Method ,Europe ,Female ,Follow-Up Studies ,Heart Failure ,Humans ,Inpatients ,Male ,Middle Aged ,Mineralocorticoid Receptor Antagonists ,Prospective Studies ,Stroke Volume ,Survival Rate ,Treatment Outcome ,United States ,Ventricular Function ,Left ,EVEREST Trial Investigators ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
Despite the well-established benefits of mineralocorticoid receptor agonists (MRAs) in heart failure with reduced ejection fraction, safety concerns remain in patients with concomitant diabetes mellitus (DM) because of common renal and electrolyte abnormalities in this population. We analyzed all-cause mortality and composite cardiovascular mortality and HF hospitalization over a median 9.9 months among 1,998 patients in the placebo arm of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) trial by DM status and discharge MRA use. Of the 750 patients with DM, 59.2% were receiving MRAs compared with 62.5% in the non-DM patients. DM patients not receiving MRAs were older, more likely to be men, with an ischemic heart failure etiology and slightly worse renal function compared with those receiving MRAs. After adjustment for baseline risk factors, among DM patients, MRA use was not associated with either mortality (hazard ratio [HR] 0.93; 95% confidence interval [CI] 0.75 to 1.15) or the composite end point (HR 0.94; 95% CI 0.80 to 1.10). Similar findings were seen in non-DM patients (mortality [HR 1.01; 95% CI 0.84 to 1.22] or the composite end point [HR 0.98; 95% CI 0.85 to 1.13] [p >0.43 for DM interaction]). In conclusion, in-hospital initiation of MRA therapy was low (15% to 20%), and overall discharge MRA use was only 60% (with regional variation), regardless of DM status. There does not appear to be clear, clinically significant in-hospital hemodynamic or even renal differences between those on and off MRA. Discharge MRA use was not associated with postdischarge end points in patients hospitalized for worsening heart failure with reduced ejection fraction and co-morbid DM. DM does not appear to influence the effectiveness of MRA therapy.
- Published
- 2014
54. Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries
- Author
-
Greene, Stephen J, Shah, Ami N, Butler, Javed, Ambrosy, Andrew P, Anker, Stefan D, Chioncel, Ovidiu, Collins, Sean P, Dinh, Wilfried, Dunnmon, Preston M, Fonarow, Gregg C, Lam, Carolyn SP, Mentz, Robert J, Pieske, Burkert, Roessig, Lothar, Rosano, Giuseppe MC, Sato, Naoki, Vaduganathan, Muthiah, and Gheorghiade, Mihai
- Subjects
Cardiovascular ,Clinical Research ,Clinical Trials and Supportive Activities ,Heart Disease ,Clinical Protocols ,Clinical Trials ,Phase II as Topic ,Clinical Trials ,Phase III as Topic ,Global Health ,Guideline Adherence ,Heart Failure ,Hospitalization ,Humans ,Multicenter Studies as Topic ,Registries ,Therapies ,Investigational ,Treatment Outcome ,Cardiorespiratory Medicine and Haematology ,Public Health and Health Services ,Cardiovascular System & Hematology - Abstract
Recent international phase III clinical trials of novel therapies for hospitalized heart failure (HHF) have failed to improve the unacceptably high postdischarge event rate. These large studies have demonstrated notable geographic and site-specific variation in patient profiles and enrollment. Possible contributors to the lack of success in HHF outcome trials include challenges in selecting clinical sites capable of (1) providing adequate numbers of appropriately selected patients and (2) properly executing the study protocol. We propose a "pretrial registry" as a novel tool for improving the efficiency and quality of international HHF trials by focusing on the selection and cultivation of high-quality sites. A pretrial registry may help assess a site's ability to achieve adequate enrollment of the target patient population, integrate protocol requirements into clinical workflow, and accomplish appropriate follow-up. Although such a process would be associated with additional upfront resource investment, this appropriation may be modest in comparison with the downstream costs associated with maintenance of poorly performing sites, failed clinical trials, and the global health and economic burden of HHF. This review is based on discussions between scientists, clinical trialists, and regulatory representatives regarding methods for improving international HHF trials that took place at the United States Food and Drug Administration on January 12th, 2012.
- Published
- 2014
55. Developing Therapies for Heart Failure With Preserved Ejection Fraction Current State and Future Directions
- Author
-
Butler, Javed, Fonarow, Gregg C, Zile, Michael R, Lam, Carolyn S, Roessig, Lothar, Schelbert, Erik B, Shah, Sanjiv J, Ahmed, Ali, Bonow, Robert O, Cleland, John GF, Cody, Robert J, Chioncel, Ovidiu, Collins, Sean P, Dunnmon, Preston, Filippatos, Gerasimos, Lefkowitz, Martin P, Marti, Catherine N, McMurray, John J, Misselwitz, Frank, Nodari, Savina, O'Connor, Christopher, Pfeffer, Marc A, Pieske, Burkert, Pitt, Bertram, Rosano, Giuseppe, Sabbah, Hani N, Senni, Michele, Solomon, Scott D, Stockbridge, Norman, Teerlink, John R, Georgiopoulou, Vasiliki V, and Gheorghiade, Mihai
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Cardiovascular ,Heart Disease ,Animals ,Clinical Trials as Topic ,Diastole ,Disease Models ,Animal ,Echocardiography ,Forecasting ,Heart Atria ,Heart Failure ,Humans ,Hypertension ,Pulmonary ,Stroke Volume ,Systole ,Treatment Outcome ,Vascular Stiffness ,Ventricular Dysfunction ,Left ,Ventricular Function ,Left ,epidemiology ,heart failure ,preserved ejection fraction ,prognosis ,treatment ,Cardiorespiratory Medicine and Haematology ,Cardiovascular medicine and haematology - Abstract
The burden of heart failure with preserved ejection fraction (HFpEF) is considerable and is projected to worsen. To date, there are no approved therapies available for reducing mortality or hospitalizations for these patients. The pathophysiology of HFpEF is complex and includes alterations in cardiac structure and function, systemic and pulmonary vascular abnormalities, end-organ involvement, and comorbidities. There remain major gaps in our understanding of HFpEF pathophysiology. To facilitate a discussion of how to proceed effectively in future with development of therapies for HFpEF, a meeting was facilitated by the Food and Drug Administration and included representatives from academia, industry, and regulatory agencies. This document summarizes the proceedings from this meeting.
- Published
- 2014
56. Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement.
- Author
-
Chioncel, Ovidiu, Čelutkienė, Jelena, Bělohlávek, Jan, Kamzola, Ginta, Lainscak, Mitja, Merkely, Béla, Miličić, Davor, Nessler, Jadwiga, Ristić, Arsen D., Sawiełajc, Lidia, Uchmanowicz, Izabella, Uuetoa, Tiina, Turgonyi, Eva, Yotov, Yoto, and Ponikowski, Piotr
- Subjects
HEALTH care teams ,MEDICAL personnel ,LITERATURE reviews ,INFRASTRUCTURE (Economics) ,MEDICAL registries ,HEART failure - Abstract
Despite improvements over recent years, morbidity and mortality associated with heart failure (HF) are higher in countries in the Central and Eastern Europe and Baltic region than in Western Europe. With the goal of improving the standard of HF care and patient outcomes in the Central and Eastern Europe and Baltic region, this review aimed to identify the main barriers to optimal HF care and potential areas for improvement. This information was used to suggest methods to improve HF management and decrease the burden of HF in the region that can be implemented at the national and regional levels. We performed a literature search to collect information about HF epidemiology in 11 countries in the region (Bulgaria, Croatia, Czechia, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Serbia, and Slovenia). The prevalence of HF in the region was 1.6–4.7%, and incidence was 3.1–6.0 per 1000 person‐years. Owing to the scarcity of published data on HF management in these countries, we also collected insights on local HF care and management practices via two surveys of 11 HF experts representing the 11 countries. Based on the combined results of the literature review and surveys, we created national HF care and management profiles for each country and developed a common patient pathway for HF for the region. We identified five main barriers to optimal HF care: (i) lack of epidemiological data, (ii) low awareness of HF, (iii) lack of national HF strategies, (iv) infrastructure and system gaps, and (v) poor access to novel HF treatments. To overcome these barriers, we propose the following routes to improvement: (i) establish regional and national prospective HF registries for the systematic collection of epidemiological data; (ii) establish education campaigns for the public, patients, caregivers, and healthcare professionals; (iii) establish formal HF strategies to set clear and measurable policy goals and support budget planning; (iv) improve access to quality‐of‐care centres, multidisciplinary care teams, diagnostic tests, and telemedicine/telemonitoring; and (v) establish national treatment monitoring programmes to develop policies that ensure that adequate proportions of healthcare budgets are reserved for novel therapies. These routes to improvement represent a first step towards improving outcomes in patients with HF in the Central and Eastern Europe and Baltic region by decreasing disparities in HF care within the region and between the region and Western Europe. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
57. Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG‐HF.
- Author
-
Voordes, Geert, Davison, Beth, Biegus, Jan, Edwards, Christopher, Damman, Kevin, ter Maaten, Jozine, Mebazaa, Alexandre, Takagi, Koji, Adamo, Marianna, Ambrosy, Andrew P., Arrigo, Mattia, Barros, Marianela, Celutkiene, Jelena, Čerlinskaitė‐Bajorė, Kamilė, Chioncel, Ovidiu, Cohen‐Solal, Alain, Damasceno, Albertino, Deniau, Benjamin, Diaz, Rafael, and Filippatos, Gerasimos
- Subjects
ADRENOMEDULLIN ,HEART failure ,PATIENT readmissions ,BRAIN natriuretic factor - Abstract
Aims: Biologically active adrenomedullin (bio‐ADM) is a promising marker of residual congestion. The STRONG‐HF trial showed that high‐intensity care (HIC) of guideline‐directed medical therapy (GDMT) improved congestion and clinical outcomes in heart failure (HF) patients. The association between bio‐ADM, decongestion, outcomes and the effect size of HIC of GDMT remains to be elucidated. Methods and results: We measured plasma bio‐ADM concentrations in 1005 patients within 2 days prior to anticipated discharge (baseline) and 90 days later. Bio‐ADM correlated with most signs of congestion, with the exception of rales. Changes in bio‐ADM were strongly correlated with change in congestion status from baseline to day 90 (gamma −0.24; p = 0.0001). Patients in the highest tertile of baseline bio‐ADM concentrations were at greater risk than patients in the lowest tertile for the primary outcome of 180‐day all‐cause mortality or HF rehospitalization (hazard ratio [HR] 2.14, 95% confidence interval [CI] 1.42–3.22) and 180‐day HF rehospitalization (HR 2.33, 95% CI 1.38–3.94). Areas under the receiver‐operating characteristic curves were 0.5977 (95% CI 0.5561–0.6393), 0.5800 (95% CI 0.5356–0.6243), and 0.6159 (95% CI 0.5711–0.6607) for bio‐ADM, N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and their combination, respectively, suggesting that both bio‐ADM and NT‐proBNP provided similarly modest discrimination for this outcome. A trend towards better discrimination by combined bio‐ADM and NT‐proBNP than NT‐proBNP alone was found (p = 0.059). HIC improved the primary outcome, irrespective of baseline bio‐ADM concentration (interaction p = 0.37). In contrast to NT‐proBNP, the 90‐day change in bio‐ADM did not differ significantly between HIC and usual care. Conclusions: Bio‐ADM is a marker of congestion and predicts congestion at 3 months after a HF hospitalization. Higher bio‐ADM was modestly associated with a higher risk of death and early hospital readmission and may have added value when combined with NT‐proBNP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
58. Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
- Author
-
Savarese, Gianluigi, Lindberg, Felix, Christodorescu, Ruxandra M., Ferrini, Marc, Kumler, Thomas, Toutoutzas, Konstantinos, Dattilo, Giuseppe, Bayes‐Genis, Antoni, Moura, Brenda, Amir, Offer, Petrie, Mark C., Seferovic, Petar, Chioncel, Ovidiu, Metra, Marco, Coats, Andrew J.S., and Rosano, Giuseppe M.C.
- Subjects
HEART failure ,VENTRICULAR ejection fraction ,PHYSICIANS ,SODIUM-glucose cotransporter 2 inhibitors ,MINERALOCORTICOID receptors - Abstract
Aims: Recent guidelines recommend four core drug classes (renin–angiotensin system inhibitor/angiotensin receptor–neprilysin inhibitor [RASi/ARNi], beta‐blocker, mineralocorticoid receptor antagonist [MRA], and sodium–glucose cotransporter 2 inhibitor [SGLT2i]) for the pharmacological management of heart failure (HF) with reduced ejection fraction (HFrEF). We assessed physicians' perceived (i) comfort with implementing the recent HFrEF guideline recommendations; (ii) status of guideline‐directed medical therapy (GDMT) implementation; (iii) use of different GDMT sequencing strategies; and (iv) barriers and strategies for achieving implementation. Methods and results: A 26‐question survey was disseminated via bulletin, e‐mail and social channels directed to physicians with an interest in HF. Of 432 respondents representing 91 countries, 36% were female, 52% were aged <50 years, and 90% mainly practiced in cardiology (30% HF). Overall comfort with implementing quadruple therapy was high (87%). Only 12% estimated that >90% of patients with HFrEF without contraindications received quadruple therapy. The time required to initiate quadruple therapy was estimated at 1–2 weeks by 34% of respondents, 1 month by 36%, 3 months by 24%, and ≥6 months by 6%. The average respondent favoured traditional drug sequencing strategies (RASi/ARNi with/followed by beta‐blocker, and then MRA with/followed by SGLT2i) over simultaneous initiation or SGLT2i‐first sequences. The most frequently perceived clinical barriers to implementation were hypotension (70%), creatinine increase (47%), hyperkalaemia (45%) and patient adherence (42%). Conclusions: Although comfort with implementing all four core drug classes in patients with HFrEF was high among physicians, a majority estimated implementation of GDMT in HFrEF to be low. We identified several important perceived clinical and non‐clinical barriers that can be targeted to improve implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
59. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission
- Author
-
Cotter, Gad, primary, Deniau, Benjamin, additional, Davison, Beth, additional, Edwards, Christopher, additional, Adamo, Marianna, additional, Arrigo, Mattia, additional, Barros, Marianela, additional, Biegus, Jan, additional, Celutkiene, Jelena, additional, Čerlinskaitė-Bajorė, Kamilė, additional, Chioncel, Ovidiu, additional, Cohen-Solal, Alain, additional, Damasceno, Albertino, additional, Diaz, Rafael, additional, Filippatos, Gerasimos, additional, Gayat, Etienne, additional, Kimmoun, Antoine, additional, Lam, Carolyn S.P., additional, Metra, Marco, additional, Novosadova, Maria, additional, Pang, Peter S., additional, Pagnesi, Matteo, additional, Ponikowski, Piotr, additional, Saidu, Hadiza, additional, Sliwa, Karen, additional, Takagi, Koji, additional, Ter Maaten, Jozine M., additional, Tomasoni, Daniela, additional, Voors, Adriaan, additional, and Mebazaa, Alexandre, additional
- Published
- 2023
- Full Text
- View/download PDF
60. Atrial fibrillation before and after transcatheter aortic valve implantation: an intertwine between survival and quality of life
- Author
-
Radulescu, Crina Ioana, primary, Chioncel, Ovidiu, additional, Metra, Marco, additional, and Adamo, Marianna, additional
- Published
- 2023
- Full Text
- View/download PDF
61. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
- Author
-
Crespo-Leiro, M., Anker, S., Mebazaa, A., Coats, A., Filippatos, G., Ferrari, R., Maggioni, A.P., Piepoli, M.F., Amir, O., Chioncel, O., Dahlström, U., Delgado Jimenez, J.F., Drozdz, J., Erglis, A., Fazlibegovic, E., Fonseca, C., Fruhwald, F., Gatzov, P., Goncalvesova, E., Hassanein, M., Hradec, J., Kavoliuniene, A., Lainscak, M., Logeart, D., Merkely, B., Metra, M., Otljanska, M., Seferovic, P.M., Srbinovska Kostovska, E., Temizhan, A., Tousoulis, D., Ferreira, T., Andarala, M., Fiorucci, E., Folkesson Lefrancq, E., Glémot, M., Gracia, G., Konte, M., Laroche, C., McNeill, P.A., Missiamenou, V., Taylor, C., Auer, J., Ablasser, K., Dolze, T., Brandner, K., Gstrein, S., Poelzl, G., Moertl, D., Reiter, S., Podczeck-Schweighofer, A., Muslibegovic, A., Vasilj, M., Cesko, M., Zelenika, D., Palic, B., Pravdic, D., Cuk, D., Vitlianova, K., Katova, T., Velikov, T., Kurteva, T., Kamenova, D., Antova, M., Sirakova, V., Krejci, J., Mikolaskova, M., Spinar, J., Krupicka, J., Malek, F., Hegarova, M., Lazarova, M., Monhart, Z., Sobhy, M., El Messiry, F., El Shazly, A.H., Elrakshy, Y., Youssef, A., Moneim, A.A., Noamany, M., Reda, A., Abdel Dayem, T.K., Farag, N., Ibrahim Halawa, S., Abdel Hamid, M., Said, K., Saleh, A., Ebeid, H., Hanna, R., Aziz, R., Louis, O., Enen, M.A., Ibrahim, B.S., Nasr, G., Elbahry, A., Sobhy, H., Ashmawy, M., Gouda, M., Aboleineen, W., Bernard, Y., Luporsi, P., Meneveau, N., Pillot, M., Morel, M., Seronde, M.-F., Schiele, F., Briand, F., Delahaye, F., Damy, T., Eicher, J.-C., de Groote, P., Fertin, M., Lamblin, N., Isnard, R., Lefol, C., Thevenin, S., Hagege, A., Jondeau, G., Le Marcis, V., Ly, J.-F., Coisne, D., Lequeux, B., Le Moal, V., Mascle, S., Lotton, P., Behar, N., Donal, E., Thebault, C., Ridard, C., Reynaud, A., Basquin, A., Bauer, F., Codjia, R., Galinier, M., Tourikis, P., Stavroula, M., Stefanadis, C., Chrysohoou, C., Kotrogiannis, I., Matzaraki, V., Dimitroula, T., Karavidas, A., Tsitsinakis, G., Kapelios, C., Nanas, J., Kampouri, H., Nana, E., Kaldara, E., Eugenidou, A., Vardas, P., Saloustros, I., Patrianakos, A., Tsaknakis, T., Evangelou, S., Nikoloulis, N., Tziourganou, H., Tsaroucha, A., Papadopoulou, A., Douras, A., Polgar, L., Kosztin, A., Nyolczas, N., Csaba Nagy, A., Halmosi, R., Elber, J., Alony, I., Shotan, A., Vazan Fuhrmann, A., Romano, S., Marcon, S., Penco, M., Di Mauro, M., Lemme, E., Carubelli, V., Rovetta, R., Bulgari, M., Quinzani, F., Lombardi, C., Bosi, S., Schiavina, G., Squeri, A., Barbieri, A., Di Tano, G., Pirelli, S., Fucili, A., Passero, T., Musio, S., Di Biase, M., Correale, M., Salvemini, G., Brognoli, S., Zanelli, E., Giordano, A., Agostoni, P., Italiano, G., Salvioni, E., Copelli, S., Modena, M.G., Reggianini, L., Valenti, C., Olaru, A., Bandino, S., Deidda, M., Mercuro, G., Cadeddu Dessalvi, C., Marino, P.N., Di Ruocco, M.V., Sartori, C., Piccinino, C., Parrinello, G., Licata, G., Torres, D., Giambanco, S., Busalacchi, S., Arrotti, S., Novo, S., Inciardi, R.M., Pieri, P., Chirco, P.R., Ausilia Galifi, M., Teresi, G., Buccheri, D., Minacapelli, A., Veniani, M., Frisinghelli, A., Priori, S.G., Cattaneo, S., Opasich, C., Gualco, A., Pagliaro, M., Mancone, M., Fedele, F., Cinque, A., Vellini, M., Scarfo, I., Romeo, F., Ferraiuolo, F., Sergi, D., Anselmi, M., Melandri, F., Leci, E., Iori, E., Bovolo, V., Pidello, S., Frea, S., Bergerone, S., Botta, M., Canavosio, F.G., Gaita, F., Merlo, M., Cinquetti, M., Sinagra, G., Ramani, F., Fabris, E., Stolfo, D., Artico, J., Miani, D., Fresco, C., Daneluzzi, C., Proclemer, A., Cicoira, M., Zanolla, L., Marchese, G., Torelli, F., Vassanelli, C., Voronina, N., Tamakauskas, V., Smalinskas, V., Karaliute, R., Petraskiene, I., Kazakauskaite, E., Rumbinaite, E., Vysniauskas, V., Brazyte-Ramanauskiene, R., Petraskiene, D., Stankala, S., Switala, P., Juszczyk, Z., Sinkiewicz, W., Gilewski, W., Pietrzak, J., Orzel, T., Kasztelowicz, P., Kardaszewicz, P., Lazorko-Piega, M., Gabryel, J., Mosakowska, K., Bellwon, J., Rynkiewicz, A., Raczak, G., Lewicka, E., Dabrowska-Kugacka, A., Bartkowiak, R., Sosnowska-Pasiarska, B., Wozakowska-Kaplon, B., Krzeminski, A., Zabojszcz, M., Mirek-Bryniarska, E., Grzegorzko, A., Bury, K., Nessler, J., Zalewski, J., Furman, A., Broncel, M., Poliwczak, A., Bala, A., Zycinski, P., Rudzinska, M., Jankowski, L., Kasprzak, J.D., Michalak, L., Wojtczak Soska, K., Huziuk, I., Retwinski, A., Flis, P., Weglarz, J., Bodys, A., Grajek, S., Kaluzna-Oleksy, M., Straburzynska-Migaj, E., Dankowski, R., Szymanowska, K., Grabia, J., Szyszka, A., Nowicka, A., Samcik, M., Wolniewicz, L., Baczynska, K., Komorowska, K., Poprawa, I., Komorowska, E., Sajnaga, D., Zolbach, A., Dudzik-Plocica, A., Abdulkarim, A.-F., Lauko-Rachocka, A., Kaminski, L., Kostka, A., Cichy, A., Ruszkowski, P., Splawski, M., Fitas, G., Szymczyk, A., Serwicka, A., Fiega, A., Zysko, D., Krysiak, W., Szabowski, S., Skorek, E., Pruszczyk, P., Bienias, P., Ciurzynski, M., Welnicki, M., Mamcarz, A., Folga, A., Zielinski, T., Rywik, T., Leszek, P., Sobieszczanska-Malek, M., Piotrowska, M., Kozar-Kaminska, K., Komuda, K., Wisniewska, J., Tarnowska, A., Balsam, P., Marchel, M., Opolski, G., Kaplon-Cieslicka, A., Gil, R.J., Mozenska, O., Byczkowska, K., Gil, K., Pawlak, A., Michalek, A., Krzesinski, P., Piotrowicz, K., Uzieblo-Zyczkowska, B., Stanczyk, A., Skrobowski, A., Ponikowski, P., Jankowska, E., Rozentryt, P., Polonski, L., Gadula-Gacek, E., Nowalany-Kozielska, E., Kuczaj, A., Kalarus, Z., Szulik, M., Przybylska, K., Klys, J., Prokop-Lewicka, G., Kleinrok, A., Tavares Aguiar, C., Ventosa, A., Pereira, S., Faria, R., Chin, J., De Jesus, I., Santos, R., Silva, P., Moreno, N., Queirós, C., Lourenço, C., Pereira, A., Castro, A., Andrade, A., Oliveira Guimaraes, T., Martins, S., Placido, R., Lima, G., Brito, D., Francisco, A.R., Cardiga, R., Proenca, M., Araujo, I., Marques, F., Moura, B., Leite, S., Campelo, M., Silva-Cardoso, J., Rodrigues, J., Rangel, I., Martins, E., Sofia Correia, A., Peres, M., Marta, L., Ferreira da Silva, G., Severino, D., Durao, D., Leao, S., Magalhaes, P., Moreira, I., Filipa Cordeiro, A., Ferreira, C., Araujo, C., Ferreira, A., Baptista, A., Radoi, M., Bicescu, G., Vinereanu, D., Sinescu, C.-J., Macarie, C., Popescu, R., Daha, I., Dan, G.-A., Stanescu, C., Dan, A., Craiu, E., Nechita, E., Aursulesei, V., Christodorescu, R., Otasevic, P., Simeunovic, D., Ristic, A.D., Celic, V., Pavlovic-Kleut, M., Suzic Lazic, J., Stojcevski, B., Pencic, B., Stevanovic, A., Andric, A., Iric-Cupic, V., Jovic, M., Davidovic, G., Milanov, S., Mitic, V., Atanaskovic, V., Antic, S., Pavlovic, M., Stanojevic, D., Stoickov, V., Ilic, S., Deljanin Ilic, M., Petrovic, D., Stojsic, S., Kecojevic, S., Dodic, S., Cemerlic Adic, N., Cankovic, M., Stojiljkovic, J., Mihajlovic, B., Radin, A., Radovanovic, S., Krotin, M., Klabnik, A., Pernicky, M., Murin, J., Kovar, F., Kmec, J., Semjanova, H., Strasek, M., Savnik Iskra, M., Ravnikar, T., Cernic Suligoj, N., Komel, J., Fras, Z., Jug, B., Glavic, T., Losic, R., Bombek, M., Krajnc, I., Krunic, B., Horvat, S., Kovac, D., Rajtman, D., Cencic, V., Letonja, M., Winkler, R., Valentincic, M., Melihen-Bartolic, C., Bartolic, A., Pusnik Vrckovnik, M., Kladnik, M., Slemenik Pusnik, C., Marolt, A., Klen, J., Drnovsek, B., Leskovar, B., Fernandez Anguita, M.J., Gallego Page, J.C., Salmeron Martinez, F.M., Andres, J., Genis, A.B., Mirabet, S., Mendez, A., Garcia-Cosio, L., Roig, E., Leon, V., Gonzalez-Costello, J., Muntane, G., Garay, A., Alcade-Martinez, V., Lopez Fernandez, S., Rivera-Lopez, R., Puga-Martinez, M., Fernandez-Alvarez, M., Serrano-Martinez, J.L., Grille-Cancela, Z., Marzoa-Rivas, R., Blanco-Canosa, P., Paniagua-Martin, M.J., Barge-Caballero, E., Laynez Cerdena, I., Famara Hernandez Baldomero, I., Lara Padron, A., Ofelia Rosillo, S., Dalmau Gonzalez-Gallarza, R., Salvador Montanes, O., Iniesta Manjavacas, A.M., Castro Conde, A., Araujo, A., Soria, T., Garcia-Pavia, P., Gomez-Bueno, M., Cobo-Marcos, M., Alonso-Pulpon, L., Segovia Cubero, J., Sayago, I., Gonzalez-Segovia, A., Briceno, A., Escribano Subias, P., Vicente Hernandez, M., Ruiz Cano, M.J., Gomez Sanchez, M.A., Barrios Garrido-Lestache, E., Garcia Pinilla, J.M., Garcia de la Villa, B., Sahuquillo, A., Bravo Marques, R., Torres Calvo, F., Perez-Martinez, M.T., Gracia-Rodenas, M.R., Garrido-Bravo, I.P., Pastor-Perez, F., Pascual-Figal, D.A., Diaz Molina, B., Orus, J., Epelde Gonzalo, F., Bertomeu, V., Valero, R., Martinez-Abellan, R., Quiles, J., Rodrigez-Ortega, J.A., Mateo, I., ElAmrani, A., Fernandez-Vivancos, C., Bierge Valero, D., Almenar-Bonet, L., Sanchez-Lazaro, I.J., Marques-Sule, E., Facila-Rubio, L., Perez-Silvestre, J., Garcia-Gonzalez, P., Ridocci-Soriano, F., Garcia-Escriva, D., Pellicer-Cabo, A., de la Fuente Galan, L., Lopez Diaz, J., Recio Platero, A., Arias, J.C., Blasco-Peiro, T., Sanz Julve, M., Sanchez-Insa, E., Aured-Guallar, C., Portoles-Ocampo, A., Melin, M., Hägglund, E., Stenberg, A., Lindahl, I.-M., Asserlund, B., Olsson, L., Afzelius, M., Karlström, P., Tengvall, L., Wiklund, P.-A., Olsson, B., Kalayci, S., Cavusoglu, Y., Gencer, E., Yilmaz, M.B., Gunes, H., Canepa, Marco, Fonseca, Candida, Chioncel, Ovidiu, Laroche, Cécile, Crespo-Leiro, Maria G., Coats, Andrew J.S., Mebazaa, Alexandre, Piepoli, Massimo F., Tavazzi, Luigi, and Maggioni, Aldo P.
- Published
- 2018
- Full Text
- View/download PDF
62. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- Author
-
McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haran, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Coats, Andrew J.S., Crespo-Leiro, Maria G., Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lam, Carolyn S.P., Lyon, Alexander R., McMurray, John J.V., Mebazaa, Alexandre, Mindham, Richard, Muneretto, Claudio, Piepoli, Massimo Francesco, Price, Susanna, Rosano, Giuseppe M.C., Ruschitzka, Frank, and Skibelund, Anne Kathrine
- Published
- 2022
- Full Text
- View/download PDF
63. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureGrupo de Trabajo de la Sociedad Europea de Cardiología (ESC) de diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónicaDesarrollada con la colaboración especial de la Heart Failure Association (HFA) de la ESC
- Author
-
McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haran, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Coats, Andrew J.S., Crespo-Leiro, María G., Farmakis, Dimitrios, Gilard, Martine, Heyman, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lam, Carolyn S.P., Lyon, Alexander R., McMurray, John J.V., Mebazaa, Alexandre, Mindham, Richard, Muneretto, Claudio, Francesco Piepoli, Massimo, Price, Susanna, Rosano, Giuseppe M.C., Ruschitzka, Frank, and Skibelund, Anne Kathrine
- Published
- 2022
- Full Text
- View/download PDF
64. Cardiogenic shock in cancer
- Author
-
Keramida, Kalliopi, Parissis, John T., Chioncel, Ovidiu, and Farmakis, Dimitrios
- Published
- 2019
- Full Text
- View/download PDF
65. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- Author
-
SALA, JORGELINA, CARTASEGNA, LUIS, VICO, MARISA, HOMINAL, MIGUEL ANGEL, HASBANI, EDUARDO, CACCAVO, ALBERTO, ZAIDMAN, CESAR, VOGEL, DANIEL, HRABAR, ADRIAN, SCHYGIEL, PABLO OMAR, CUNEO, CARLOS, LUQUEZ, HUGO, MACKINNON, IGNACIO J., AHUAD GUERRERO, RODOLFO ANDRES, COSTABEL, JUAN PABLO, BARTOLACCI, INES PALMIRA, MONTANA, OSCAR, BARBIERI, MARIA, GOMEZ VILAMAJO, OSCAR, GARCIA DURAN, RUBEN OMAR, SCHIAVI, LILIA BEATRIZ, GARRIDO, MARCELO, INGARAMO, ADRIAN, BORDONAVA, ANSELMO PAULINO, PELAGAGGE, MARIA JOSE, NOVARETTO, LEONARDO, ALBISU DI GENNERO, JUAN PABLO, IBANEZ SAGGIA, LUZ MARIA, ALVAREZ, MOIRA, VITA, NESTOR ALEJANDRO, MACIN, STELLA MARIS, DRAN, RICARDO DARIO, CARDONA, MARCELO, GUZMAN, LUIS, SARJANOVICH, RODOLFO JUAN, CUADRADO, JESUS, NANI, SEBASTIAN, LITVAK BRUNO, MARCOS RAUL, CHACON, CAROLINA, MAFFEI, LAURA ELENA, GRINFELD, DIEGO, VENSENTINI, NATALIA, MAJUL, CLAUDIO RODOLFO, LUCIARDI, HECTOR LUCAS, GONZALEZ COLASO, PATRICIA DEL CARMEN, FERRE PACORA, FREDY ANTONI, VAN DEN HEUVEL, PAUL, VERHAMME, PETER, ECTOR, BAVO, DEBONNAIRE, PHILIPPE, VAN DE BORNE, PHILIPPE, LEROY, JEAN, SCHROE, HERMAN, VRANCKX, PASCAL, ELEGEERT, IVAN, HOFFER, ETIENNE, DUJARDIN, KARL, INDIO DO BRASIL, CLARISSE, PRECOMA, DALTON, ABRANTES, JOSE ANTONIO, MANENTI, EULER, REIS, GILMAR, SARAIVA, JOSE, MAIA, LILIA, HERNANDES, MAURO, ROSSI, PAULO, ROSSI DOS SANTOS, FABIO, ZIMMERMANN, SERGIO LUIZ, RECH, RAFAEL, ABIB JR, EDUARDO, LEAES, PAULO, BOTELHO, ROBERTO, DUTRA, OSCAR, SOUZA, WEIMAR, BRAILE, MARIA, IZUKAWA, NILO, NICOLAU, JOSE CARLOS, TANAJURA, LUIZ FERNANDO, SERRANO JUNIOR, CARLOS VICENTE, MINELLI, CESAR, NASI, LUIZ ANTONIO, OLIVEIRA, LIVIA, DE CARVALHO CANTARELLI, MARCELO JOSE, TYTUS, RICHARD, PANDEY, SHEKHAR, LONN, EVA, CHA, JAMES, VIZEL, SAUL, BABAPULLE, MOHAN, LAMY, ANDRE, SAUNDERS, KEVIN, BERLINGIERI, JOSEPH, KIAII, BOB, BHARGAVA, RAKESH, MEHTA, PRAVINSAGAR, HILL, LAURIE, FELL, DAVID, LAM, ANDY, AL-QOOFI, FAISAL, BROWN, CRAIG, PETRELLA, ROBERT, RICCI, JOSEPH A, GLANZ, ANTHONY, NOISEUX, NICOLAS, BAINEY, KEVIN, MERALI, FATIMA, HEFFERNAN, MICHAEL, DELLA SIEGA, ANTHONY, DAGENAIS, GILLES R, DAGENAIS, FRANCOIS, BRULOTTE, STEEVE, NGUYEN, MICHEL, HARTLEIB, MICHAEL, GUZMAN, RANDOLPH, BOURGEOIS, RONALD, RUPKA, DENNIS, KHAYKIN, YAARIV, GOSSELIN, GILBERT, HUYNH, THAO, PILON, CLAUDE, CAMPEAU, JEAN, PICHETTE, FRANCIS, DIAZ, ARIEL, JOHNSTON, JAMES, SHUKLE, PRAVIN, HIRSCH, GREGORY, RHEAULT, PAUL, CZARNECKI, WLODZIMIERZ, ROY, ANNIE, NAWAZ, SHAH, FREMES, STEPHEN, SHUKLA, DINKAR, JANO, GABRIEL, COBOS, JORGE LEONARDO, CORBALAN, RAMON, MEDINA, MARCELO, NAHUELPAN, LEONARDO, RAFFO, CARLOS, PEREZ, LUIS, POTTHOFF, SERGIO, STOCKINS, BENJAMIN, SEPULVEDA, PABLO, PINCETTI, CHRISTIAN, VEJAR, MARGARITA, TIAN, HONGYAN, WU, XUESI, KE, YUANNAN, JIA, KAIYING, YIN, PENGFEI, WANG, ZHAOHUI, YU, LITIAN, WU, SHULIN, WU, ZONGQUI, LIU, SHAO WEN, BAI, XIAO JUAN, ZHENG, YANG, YANG, PING, YANG, YUN MEI, ZHANG, JIWEI, GE, JUNBO, CHEN, XIAO PING, LI, JUNXIA, HU, TAO HONG, ZHANG, RUIYAN, ZHENG, ZHE, CHEN, XIN, TAO, LIANG, LI, JIANPING, HUANG, WEIJIAN, FU, GUOSHENG, LI, CHUNJIAN, DONG, YUGANG, WANG, CHUNSHENG, ZHOU, XINMIN, KONG, YE, SOTOMAYOR, ARISTIDES, ACCINI MENDOZA, JOSE LUIS, CASTILLO, HENRY, URINA, MIGUEL, AROCA, GUSTAVO, PEREZ, MARITZA, MOLINA DE SALAZAR, DORA INES, SANCHEZ VALLEJO, GREGORIO, FERNANDO, MANZUR J, GARCIA, HENRY, GARCIA, LUIS HERNANDO, ARCOS, EDGAR, GOMEZ, JUAN, CUERVO MILLAN, FRANCISCO, TRUJILLO DADA, FREDY ALBERTO, VESGA, BORIS, MORENO SILGADO, GUSTAVO ADOLFO, ZIDKOVA, EVA, LUBANDA, JEAN-CLAUDE, KALETOVA, MARKETA, KRYZA, RADIM, MARCINEK, GABRIEL, RICHTER, MAREK, SPINAR, JINDRICH, MATUSKA, JIRI, TESAK, MARTIN, MOTOVSKA, ZUZANA, BRANNY, MARIAN, MALY, JIRI, MALY, MARTIN, WIENDL, MARTIN, FOLTYNOVA CAISOVA, LENKA, SLABY, JOSEF, VOJTISEK, PETR, PIRK, JAN, SPINAROVA, LENKA, BENESOVA, MIROSLAVA, CANADYOVA, JULIA, HOMZA, MIROSLAV, FLORIAN, JINDRICH, POLASEK, ROSTISLAV, COUFAL, ZDENEK, SKALNIKOVA, VLADIMIRA, BRAT, RADIM, BRTKO, MIROSLAV, JANSKY, PETR, LINDNER, JAROSLAV, MARCIAN, PAVEL, STRAKA, ZBYNEK, TRETINA, MARTIN, DUARTE, YAN CARLOS, POW CHON LONG, FREDDY, SANCHEZ, MAYRA, LOPEZ, JOSE, PERUGACHI, CARMITA, MARMOL, RICARDO, TRUJILLO, FREDDY, TERAN, PABLO, TUOMILEHTO, JAAKKO, TUOMILEHTO, HENRI, TUOMINEN, MARJA-LEENA, KANTOLA, ILKKA, STEG, GABRIEL, ABOYANS, VICTOR, LECLERCQ, FLORENCE, FERRARI, EMILE, BOCCARA, FRANCK, MESSAS, EMMANUEL, MISMETTI, PATRICK, SEVESTRE, MARIE ANTOINETTE, CAYLA, GUILLAUME, MOTREFF, PASCAL, STOERK, STEFAN, DUENGEN, HANS-DIRK, STELLBRINK, CHRISTOPH, GUEROCAK, OSMAN, KADEL, CHRISTOPH, BRAUN-DULLAEUS, RUEDIGER, JESERICH, MICHAEL, OPITZ, CHRISTIAN, VOEHRINGER, HANS-FRIEDRICH, APPEL, KARL-FRIEDRICH, WINKELMANN, BERNHARD, DORSEL, THOMAS, NIKOL, SIGRID, DARIUS, HARALD, RANFT, JURGEN, SCHELLONG, SEBASTIAN, JUNGMAIR, WOLFGANG, DAVIERWALA, PIROZE, VORPAHL, MARC, BAJNOK, LASZLO, LASZLO, ZOLTAN, NOORI, EBRAHIM, VERESS, GABOR, VERTES, ANDRAS, ZSARY, ANDRAS, KIS, ERNO, KORANYI, LASZLO, BAKAI, JUDIT, BODA, ZOLTAN, POOR, FERENC, JARAI, ZOLTAN, KEMENY, VENDEL, BARTON, JOHN, MCADAM, BRENDAN, MURPHY, ANDREW, CREAN, PETER, MAHON, NIALL, CURTIN, RONAN, MACNEILL, BRIAIN, DINNEEN, SEAN, HALABI, MAJDI, ZIMLICHMAN, REUVEN, ZELTSER, DAVID, TURGEMAN, YOAV, KLAINMAN, ELIEZER, LEWIS, BASIL, KATZ, AMOS, ATAR, SHAUL, NIKOLSKY, EUGENIA, BOSI, STEFANO, NALDI, MONICA, FAGGIANO, POMPILIO, ROBBA, DEBORA, MOS, LUCIO, SINAGRA, GIANFRANCO, COSMI, FRANCO, OLTRONA VISCONTI, LUIGI, CARMINE, DE MATTEIS, DI PASQUALE, GIUSEPPE, DI BIASE, MATTEO, MANDORLA, SARA, BERNARDINANGELI, MARINO, PICCINNI, GIOVANNI CARLO, GULIZIA, MICHELE MASSIMO, GALVANI, MARCELLO, VENTURI, FLAVIO, MOROCUTTI, GIORGIO, BALDIN, MARIA GRAZIA, OLIVIERI, CARLO, PERNA, GIAN PIERO, CIRRINCIONE, VINCENZO, KANNO, TAKAYASU, DAIDA, HIROYUKI, OZAKI, YUKIO, MIYAMOTO, NAOMASA, HIGASHIUE, SHINICHI, DOMAE, HIROSHI, HOSOKAWA, SHINOBU, KOBAYASHI, HIROO, KURAMOCHI, TAKEHIKO, FUJII, KENSHI, MIZUTOMI, KAZUAKI, SAKU, KEIJIRO, KIMURA, KAZUO, HIGUCHI, YOSHIHARU, ABE, MITSUNORI, OKUDA, HARUHITO, NODA, TOSHIYUKI, MITA, TERUAKI, HIRAYAMA, ATSUSHI, ONAKA, HARUHIKO, INOKO, MORIAKI, HIROKAMI, MITSUGU, OKUBO, MUNENORI, AKATSUKA, YUTAKA, IMAMAKI, MIZUHO, KAMIYA, HARUO, MANITA, MAMORU, HIMI, TOSHIHARU, UENO, HIDEKI, HISAMATSU, YUJI, AKO, JUNYA, NISHINO, YASUHIRO, KAWAKAMI, HIDEO, YAMADA, YUTAKA, KORETSUNE, YUKIHIRO, YAMADA, TAKAHISA, YOSHIDA, TETSURO, SHIMOMURA, HIDEKI, KINOSHITA, NORIYUKI, TAKAHASHI, AKIHIKO, YUSOFF, KHALID, WAN AHMAD, WAN AZMAN, ABU HASSAN, MUHAMMAD RADZI, KASIM, SAZZLI, ABDUL RAHIM, AIZAI AZAN, MOHD ZAMRIN, DIMON, MACHIDA, MASAHARU, HIGASHINO, YORIHIKO, UTSU, NORIAKI, NAKANO, AKIHIKO, NAKAMURA, SHIGERU, HASHIMOTO, TETSUO, ANDO, KENJI, SAKAMOTO, TOMOHIRO, PRINS, F.J., LOK, DIRK, MILHOUS, JOHANNES GERT-JAN, VIERGEVER, ERIC, WILLEMS, FRANK, SWART, HENK, ALINGS, MARCO, BREEDVELD, ROB, DE VRIES, KEES-JAN, VAN DER BORGH, ROGER, OEI, FANNY, ZOET-NUGTEREN, STIENEKE, KRAGTEN, HANS, HERRMAN, JEAN PAUL, VAN BERGEN, PAUL, GOSSELINK, MARCEL, HOEKSTRA, EDUARD, ZEGERS, ERWIN, RONNER, EELKO, DEN HARTOG, FRANK, BARTELS, GERARD, NIEROP, PETER, VAN DER ZWAAN, COEN, VAN ECK, JACOB, VAN GORSELEN, EDWIN, GROENEMEIJER, BJORN, HOOGSLAG, PIETER, DE GROOT, MARC ROBERT, LOYOLA, ALDRIN, SULIT, DENNIS JOSE, REY, NANNETTE, ABOLA, MARIA TERESA, MORALES, DANTE, PALOMARES, ELLEN, ABAT, MARC EVANS, ROGELIO, GREGORIO, CHUA, PHILIP, DEL PILAR, JOSE CARLO, ALCARAZ, JOHN DENNIS, EBO, GERALDINE, TIRADOR, LOUIE, CRUZ, JOSEFINA, ANONUEVO, JOHN, PITARGUE, ARTHUR, JANION, MARIANNA, GUZIK, TOMASZ, GAJOS, GRZEGORZ, ZABOWKA, MACIEJ, RYNKIEWICZ, ANDRZEJ, BRONCEL, MARLENA, SZUBA, ANDRZEJ, CZARNECKA, DANUTA, MAGA, PAWEL, STRAZHESKO, IRINA, VASYUK, YURY, SIZOVA, ZHANNA, POZDNYAKOV, YURY, BARBARASH, OLGA, VOEVODA, MIKHAIL, POPONINA, TATIANA, REPIN, ALEXEY, OSIPOVA, IRINA, EFREMUSHKINA, ANNA, NOVIKOVA, NINA, AVERKOV, OLEG, ZATEYSHCHIKOV, DMITRY, VERTKIN, ARKADIY, AUSHEVA, AZA, COMMERFORD, PATRICK, SEEDAT, SAADIYA, VAN ZYL, LOUIS, ENGELBRECHT, JAN, MAKOTOKO, ELLEN MAKONLI, PRETORIUS, CATHARINA ELIZABETH, MOHAMED, ZAID, HORAK, ADRIAN, MABIN, THOMAS, KLUG, ERIC, BAE, JANG-HO, KIM, CHEOLHO, KIM, CHONG-JIN, KIM, DONG-SOO, KIM, YONG JIN, JOO, SEUNGJAE, HA, JONG-WON, PARK, CHUL SOO, KIM, JANG YOUNG, KIM, YOUNG-KWON, JARNERT, CHRISTINA, MOOE, THOMAS, DELLBORG, MIKAEL, TORSTENSSON, INGEMAR, ALBERTSSON, PER, JOHANSSON, LARS, AL-KHALILI, FARIS, ALMROTH, HENRIK, ANDERSSON, TOMMY, PANTEV, EMIL, TENGMARK, BENGT-OLOV, LIU, BO, RASMANIS, GUNDARS, WAHLGREN, CARL-MAGNUS, MOCCETTI, TIZIANO, PARKHOMENKO, ALEXANDER, TSELUYKO, VIRA, VOLKOV, VOLODYMYR, KOVAL, OLENA, KONONENKO, LYUDMYLA, PROKHOROV, OLEKSANDR, VDOVYCHENKO, VALERIY, BAZYLEVYCH, ANDRIY, RUDENKO, LEONID, VIZIR, VADYM, KARPENKO, OLEKSANDR, MALYNOVSKY, YAROSLAV, KOVAL, VALENTYNA, STOROZHUK, BORYS, COTTON, JAMES, VENKATARAMAN, ASOK, MORIARTY, ANDREW, CONNOLLY, DEREK, DAVEY, PATRICK, SENIOR, ROXY, BIRDI, INDERPAUL, CALVERT, JOHN, DONNELLY, PATRICK, TREVELYAN, JASPER, CARTER, JUSTIN, PEACE, AARON, AUSTIN, DAVID, KUKREJA, NEVILLE, HILTON, THOMAS, SRIVASTAVA, SUNNY, WALSH, RONALD, FIELDS, RONALD, HAKAS, JOSEPH, PORTNAY, EDWARD, GOGIA, HARINDER, SALACATA, ABRAHAM, HUNTER, JOHN J., BACHARACH, J MICHAEL, SHAMMAS, NICOLAS, SURESH, DAMODHAR, SCHNEIDER, RICKY, GURBEL, PAUL, BANERJEE, SUBHASH, GRENA, PAUL, BEDWELL, NOEL, SLOAN, STEPHEN, LUPOVITCH, STEVEN, SONI, ANAND, GIBSON, KATHLEEN, SANGRIGOLI, RENEE, MEHTA, RAJENDRA, I-HSUAN TSAI, PETER, GILLESPIE, EVE, DEMPSEY, STEPHEN, HAMROFF, GLENN, BLACK, ROBERT, LADER, ELLIS, KOSTIS, JOHN B., BITTNER, VERA, MCGUINN, WILLIAM, BRANCH, KELLEY, MALHOTRA, VINAY, MICHAELSON, STEPHEN, VACANTE, MICHAEL, MCCORMICK, MATTHEW, ARIMIE, RALUCA, CAMP, ALAN, DAGHER, GEORGE, KOSHY, N. MATHEW, THEW, STEPHEN, COSTELLO, FREDERICK, HEIMAN, MARK, CHILTON, ROBERT, MORAN, MICHAEL, ADLER, FREDRIC, COMEROTA, ANTHONY, SEIWERT, ANDREW, FRENCH, WILLIAM, SEROTA, HARVEY, HARRISON, ROBERT, BAKAEEN, FAISAL, OMER, SHUAB, CHANDRA, LOKESH, WHELAN, ALAN, BOYLE, ANDREW, ROBERTS-THOMSON, PHILIP, ROGERS, JAMES, CARROLL, PATRICK, COLQUHOUN, DAVID, SHAW, JAMES, BLOMBERY, PETER, AMERENA, JOHN, HII, CHRIS, ROYSE, ALISTAIR, SINGH, BHUWAN, SELVANAYAGAM, JOSEPH, JANSEN, SHIRLEY, LO, WINGCHI, HAMMETT, CHRISTOPHER, POULTER, ROHAN, NARASIMHAN, SESHASAYEE, WIGGERS, HENRIK, NIELSEN, HENRIK, GISLASON, GUNNAR, KOBER, LARS, HOULIND, KIM, BOENELYKKE SOERENSEN, VIBEKE, DIXEN, ULRIK, REFSGAARD, JENS, ZEUTHEN, ELISABETH, SOEGAARD, PETER, HRANAI, MARIAN, GASPAR, LUDOVIT, PELLA, DANIEL, HATALOVA, KATARINA, DROZDAKOVA, ERIKA, COMAN, IOAN, DIMULESCU, DOINA, VINEREANU, DRAGOS, CINTEZA, MIRCEA, SINESCU, CRINA, ARSENESCU, CATALINA, BENEDEK, IMRE, BOBESCU, ELENA, DOBREANU, DAN, GAITA, DAN, IANCU, ADRIAN, ILIESIU, ADRIANA, LIGHEZAN, DANIEL, PETRESCU, LUCIAN, PIRVU, OCTAVIAN, TEODORESCU, IULIA, TESLOIANU, DAN, VINTILA, MARIUS MARCIAN, CHIONCEL, OVIDIU, Connolly, Stuart J, Eikelboom, John W, Bosch, Jackie, Dagenais, Gilles, Dyal, Leanne, Lanas, Fernando, Metsarinne, Kaj, O'Donnell, Martin, Dans, Anthony L, Ha, Jong-Won, Parkhomenko, Alexandr N, Avezum, Alvaro A, Lonn, Eva, Lisheng, Liu, Torp-Pedersen, Christian, Widimsky, Petr, Maggioni, Aldo P, Felix, Camilo, Keltai, Katalin, Hori, Masatsugu, Yusoff, Khalid, Guzik, Tomasz J, Bhatt, Deepak L, Branch, Kelley R H, Cook Bruns, Nancy, Berkowitz, Scott D, Anand, Sonia S, Varigos, John D, Fox, Keith A A, and Yusuf, Salim
- Published
- 2018
- Full Text
- View/download PDF
66. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- Author
-
SALA, JORGELINA, CARTASEGNA, LUIS, VICO, MARISA, HOMINAL, MIGUEL ANGEL, HASBANI, EDUARDO, CACCAVO, ALBERTO, ZAIDMAN, CESAR, VOGEL, DANIEL, HRABAR, ADRIAN, SCHYGIEL, PABLO OMAR, CUNEO, CARLOS, LUQUEZ, HUGO, MACKINNON, IGNACIO J., AHUAD GUERRERO, RODOLFO ANDRES, COSTABEL, JUAN PABLO, BARTOLACCI, INES PALMIRA, MONTANA, OSCAR, BARBIERI, MARIA, GOMEZ VILAMAJO, OSCAR, GARCIA DURAN, RUBEN OMAR, SCHIAVI, LILIA BEATRIZ, GARRIDO, MARCELO, INGARAMO, ADRIAN, BORDONAVA, ANSELMO PAULINO, PELAGAGGE, MARIA JOSE, NOVARETTO, LEONARDO, ALBISU DI GENNERO, JUAN PABLO, IBANEZ SAGGIA, LUZ MARIA, ALVAREZ, MOIRA, VITA, NESTOR ALEJANDRO, MACIN, STELLA MARIS, DRAN, RICARDO DARIO, CARDONA, MARCELO, GUZMAN, LUIS, SARJANOVICH, RODOLFO JUAN, CUADRADO, JESUS, NANI, SEBASTIAN, LITVAK BRUNO, MARCOS RAUL, CHACON, CAROLINA, MAFFEI, LAURA ELENA, GRINFELD, DIEGO, VENSENTINI, NATALIA, MAJUL, CLAUDIO RODOLFO, LUCIARDI, HECTOR LUCAS, GONZALEZ COLASO, PATRICIA DEL CARMEN, FERRE PACORA, FREDY ANTONI, VAN DEN HEUVEL, PAUL, VERHAMME, PETER, ECTOR, BAVO, DEBONNAIRE, PHILIPPE, VAN DE BORNE, PHILIPPE, LEROY, JEAN, SCHROE, HERMAN, VRANCKX, PASCAL, ELEGEERT, IVAN, HOFFER, ETIENNE, DUJARDIN, KARL, INDIO DO BRASIL, CLARISSE, PRECOMA, DALTON, ABRANTES, JOSE ANTONIO, MANENTI, EULER, REIS, GILMAR, SARAIVA, JOSE, MAIA, LILIA, HERNANDES, MAURO, ROSSI, PAULO, ROSSI DOS SANTOS, FABIO, ZIMMERMANN, SERGIO LUIZ, RECH, RAFAEL, ABIB JR, EDUARDO, LEAES, PAULO, BOTELHO, ROBERTO, DUTRA, OSCAR, SOUZA, WEIMAR, BRAILE, MARIA, IZUKAWA, NILO, NICOLAU, JOSE CARLOS, TANAJURA, LUIZ FERNANDO, SERRANO JUNIOR, CARLOS VICENTE, MINELLI, CESAR, NASI, LUIZ ANTONIO, OLIVEIRA, LIVIA, DE CARVALHO CANTARELLI, MARCELO JOSE, TYTUS, RICHARD, PANDEY, SHEKHAR, LONN, EVA, CHA, JAMES, VIZEL, SAUL, BABAPULLE, MOHAN, LAMY, ANDRE, SAUNDERS, KEVIN, BERLINGIERI, JOSEPH, KIAII, BOB, BHARGAVA, RAKESH, MEHTA, PRAVINSAGAR, HILL, LAURIE, FELL, DAVID, LAM, ANDY, AL-QOOFI, FAISAL, BROWN, CRAIG, PETRELLA, ROBERT, RICCI, JOSEPH A, GLANZ, ANTHONY, NOISEUX, NICOLAS, BAINEY, KEVIN, MERALI, FATIMA, HEFFERNAN, MICHAEL, DELLA SIEGA, ANTHONY, DAGENAIS, GILLES R, DAGENAIS, FRANCOIS, BRULOTTE, STEEVE, NGUYEN, MICHEL, HARTLEIB, MICHAEL, GUZMAN, RANDOLPH, BOURGEOIS, RONALD, RUPKA, DENNIS, KHAYKIN, YAARIV, GOSSELIN, GILBERT, HUYNH, THAO, PILON, CLAUDE, CAMPEAU, JEAN, PICHETTE, FRANCIS, DIAZ, ARIEL, JOHNSTON, JAMES, SHUKLE, PRAVIN, HIRSCH, GREGORY, RHEAULT, PAUL, CZARNECKI, WLODZIMIERZ, ROY, ANNIE, NAWAZ, SHAH, FREMES, STEPHEN, SHUKLA, DINKAR, JANO, GABRIEL, COBOS, JORGE LEONARDO, CORBALAN, RAMON, MEDINA, MARCELO, NAHUELPAN, LEONARDO, RAFFO, CARLOS, PEREZ, LUIS, POTTHOFF, SERGIO, STOCKINS, BENJAMIN, SEPULVEDA, PABLO, PINCETTI, CHRISTIAN, VEJAR, MARGARITA, TIAN, HONGYAN, WU, XUESI, KE, YUANNAN, JIA, KAIYING, YIN, PENGFEI, WANG, ZHAOHUI, YU, LITIAN, WU, SHULIN, WU, ZONGQUI, LIU, SHAO WEN, BAI, XIAO JUAN, ZHENG, YANG, YANG, PING, YANG, YUN MEI, ZHANG, JIWEI, GE, JUNBO, CHEN, XIAO PING, LI, JUNXIA, HU, TAO HONG, ZHANG, RUIYAN, ZHENG, ZHE, CHEN, XIN, TAO, LIANG, LI, JIANPING, HUANG, WEIJIAN, FU, GUOSHENG, LI, CHUNJIAN, DONG, YUGANG, WANG, CHUNSHENG, ZHOU, XINMIN, KONG, YE, SOTOMAYOR, ARISTIDES, ACCINI MENDOZA, JOSE LUIS, CASTILLO, HENRY, URINA, MIGUEL, AROCA, GUSTAVO, PEREZ, MARITZA, MOLINA DE SALAZAR, DORA INES, SANCHEZ VALLEJO, GREGORIO, FERNANDO, MANZUR J, GARCIA, HENRY, GARCIA, LUIS HERNANDO, ARCOS, EDGAR, GOMEZ, JUAN, CUERVO MILLAN, FRANCISCO, TRUJILLO DADA, FREDY ALBERTO, VESGA, BORIS, MORENO SILGADO, GUSTAVO ADOLFO, ZIDKOVA, EVA, LUBANDA, JEAN-CLAUDE, KALETOVA, MARKETA, KRYZA, RADIM, MARCINEK, GABRIEL, RICHTER, MAREK, SPINAR, JINDRICH, MATUSKA, JIRI, TESAK, MARTIN, MOTOVSKA, ZUZANA, BRANNY, MARIAN, MALY, JIRI, MALY, MARTIN, WIENDL, MARTIN, FOLTYNOVA CAISOVA, LENKA, SLABY, JOSEF, VOJTISEK, PETR, PIRK, JAN, SPINAROVA, LENKA, BENESOVA, MIROSLAVA, CANADYOVA, JULIA, HOMZA, MIROSLAV, FLORIAN, JINDRICH, POLASEK, ROSTISLAV, COUFAL, ZDENEK, SKALNIKOVA, VLADIMIRA, BRAT, RADIM, BRTKO, MIROSLAV, JANSKY, PETR, LINDNER, JAROSLAV, MARCIAN, PAVEL, STRAKA, ZBYNEK, TRETINA, MARTIN, DUARTE, YAN CARLOS, POW CHON LONG, FREDDY, SANCHEZ, MAYRA, LOPEZ, JOSE, PERUGACHI, CARMITA, MARMOL, RICARDO, TRUJILLO, FREDDY, TERAN, PABLO, TUOMILEHTO, JAAKKO, TUOMILEHTO, HENRI, TUOMINEN, MARJA-LEENA, KANTOLA, ILKKA, STEG, GABRIEL, ABOYANS, VICTOR, LECLERCQ, FLORENCE, FERRARI, EMILE, BOCCARA, FRANCK, MESSAS, EMMANUEL, MISMETTI, PATRICK, SEVESTRE, MARIE ANTOINETTE, CAYLA, GUILLAUME, MOTREFF, PASCAL, STOERK, STEFAN, DUENGEN, HANS-DIRK, STELLBRINK, CHRISTOPH, GUEROCAK, OSMAN, KADEL, CHRISTOPH, BRAUN-DULLAEUS, RUEDIGER, JESERICH, MICHAEL, OPITZ, CHRISTIAN, VOEHRINGER, HANS-FRIEDRICH, APPEL, KARL-FRIEDRICH, WINKELMANN, BERNHARD, DORSEL, THOMAS, NIKOL, SIGRID, DARIUS, HARALD, RANFT, JURGEN, SCHELLONG, SEBASTIAN, JUNGMAIR, WOLFGANG, DAVIERWALA, PIROZE, VORPAHL, MARC, BAJNOK, LASZLO, LASZLO, ZOLTAN, NOORI, EBRAHIM, VERESS, GABOR, VERTES, ANDRAS, ZSARY, ANDRAS, KIS, ERNO, KORANYI, LASZLO, BAKAI, JUDIT, BODA, ZOLTAN, POOR, FERENC, JARAI, ZOLTAN, KEMENY, VENDEL, BARTON, JOHN, MCADAM, BRENDAN, MURPHY, ANDREW, CREAN, PETER, MAHON, NIALL, CURTIN, RONAN, MACNEILL, BRIAIN, DINNEEN, SEAN, HALABI, MAJDI, ZIMLICHMAN, REUVEN, ZELTSER, DAVID, TURGEMAN, YOAV, KLAINMAN, ELIEZER, LEWIS, BASIL, KATZ, AMOS, ATAR, SHAUL, NIKOLSKY, EUGENIA, BOSI, STEFANO, NALDI, MONICA, FAGGIANO, POMPILIO, ROBBA, DEBORA, MOS, LUCIO, SINAGRA, GIANFRANCO, COSMI, FRANCO, OLTRONA VISCONTI, LUIGI, CARMINE, DE MATTEIS, DI PASQUALE, GIUSEPPE, DI BIASE, MATTEO, MANDORLA, SARA, BERNARDINANGELI, MARINO, PICCINNI, GIOVANNI CARLO, GULIZIA, MICHELE MASSIMO, GALVANI, MARCELLO, VENTURI, FLAVIO, MOROCUTTI, GIORGIO, BALDIN, MARIA GRAZIA, OLIVIERI, CARLO, PERNA, GIAN PIERO, CIRRINCIONE, VINCENZO, KANNO, TAKAYASU, DAIDA, HIROYUKI, OZAKI, YUKIO, MIYAMOTO, NAOMASA, HIGASHIUE, SHINICHI, DOMAE, HIROSHI, HOSOKAWA, SHINOBU, KOBAYASHI, HIROO, KURAMOCHI, TAKEHIKO, FUJII, KENSHI, MIZUTOMI, KAZUAKI, SAKU, KEIJIRO, KIMURA, KAZUO, HIGUCHI, YOSHIHARU, ABE, MITSUNORI, OKUDA, HARUHITO, NODA, TOSHIYUKI, MITA, TERUAKI, HIRAYAMA, ATSUSHI, ONAKA, HARUHIKO, INOKO, MORIAKI, HIROKAMI, MITSUGU, OKUBO, MUNENORI, AKATSUKA, YUTAKA, IMAMAKI, MIZUHO, KAMIYA, HARUO, MANITA, MAMORU, HIMI, TOSHIHARU, UENO, HIDEKI, HISAMATSU, YUJI, AKO, JUNYA, NISHINO, YASUHIRO, KAWAKAMI, HIDEO, YAMADA, YUTAKA, KORETSUNE, YUKIHIRO, YAMADA, TAKAHISA, YOSHIDA, TETSURO, SHIMOMURA, HIDEKI, KINOSHITA, NORIYUKI, TAKAHASHI, AKIHIKO, YUSOFF, KHALID, WAN AHMAD, WAN AZMAN, ABU HASSAN, MUHAMMAD RADZI, KASIM, SAZZLI, ABDUL RAHIM, AIZAI AZAN, MOHD ZAMRIN, DIMON, MACHIDA, MASAHARU, HIGASHINO, YORIHIKO, UTSU, NORIAKI, NAKANO, AKIHIKO, NAKAMURA, SHIGERU, HASHIMOTO, TETSUO, ANDO, KENJI, SAKAMOTO, TOMOHIRO, PRINS, F.J., LOK, DIRK, MILHOUS, JOHANNES GERT-JAN, VIERGEVER, ERIC, WILLEMS, FRANK, SWART, HENK, ALINGS, MARCO, BREEDVELD, ROB, DE VRIES, KEES-JAN, VAN DER BORGH, ROGER, OEI, FANNY, ZOET-NUGTEREN, STIENEKE, KRAGTEN, HANS, HERRMAN, JEAN PAUL, VAN BERGEN, PAUL, GOSSELINK, MARCEL, HOEKSTRA, EDUARD, ZEGERS, ERWIN, RONNER, EELKO, DEN HARTOG, FRANK, BARTELS, GERARD, NIEROP, PETER, VAN DER ZWAAN, COEN, VAN ECK, JACOB, VAN GORSELEN, EDWIN, GROENEMEIJER, BJORN, HOOGSLAG, PIETER, DE GROOT, MARC ROBERT, LOYOLA, ALDRIN, SULIT, DENNIS JOSE, REY, NANNETTE, ABOLA, MARIA TERESA, MORALES, DANTE, PALOMARES, ELLEN, ABAT, MARC EVANS, ROGELIO, GREGORIO, CHUA, PHILIP, DEL PILAR, JOSE CARLO, ALCARAZ, JOHN DENNIS, EBO, GERALDINE, TIRADOR, LOUIE, CRUZ, JOSEFINA, ANONUEVO, JOHN, PITARGUE, ARTHUR, JANION, MARIANNA, GUZIK, TOMASZ, GAJOS, GRZEGORZ, ZABOWKA, MACIEJ, RYNKIEWICZ, ANDRZEJ, BRONCEL, MARLENA, SZUBA, ANDRZEJ, CZARNECKA, DANUTA, MAGA, PAWEL, STRAZHESKO, IRINA, VASYUK, YURY, SIZOVA, ZHANNA, POZDNYAKOV, YURY, BARBARASH, OLGA, VOEVODA, MIKHAIL, POPONINA, TATIANA, REPIN, ALEXEY, OSIPOVA, IRINA, EFREMUSHKINA, ANNA, NOVIKOVA, NINA, AVERKOV, OLEG, ZATEYSHCHIKOV, DMITRY, VERTKIN, ARKADIY, AUSHEVA, AZA, COMMERFORD, PATRICK, SEEDAT, SAADIYA, VAN ZYL, LOUIS, ENGELBRECHT, JAN, MAKOTOKO, ELLEN MAKONLI, PRETORIUS, CATHARINA ELIZABETH, MOHAMED, ZAID, HORAK, ADRIAN, MABIN, THOMAS, KLUG, ERIC, BAE, JANG-HO, KIM, CHEOLHO, KIM, CHONG-JIN, KIM, DONG-SOO, KIM, YONG JIN, JOO, SEUNGJAE, HA, JONG-WON, PARK, CHUL SOO, KIM, JANG YOUNG, KIM, YOUNG-KWON, JARNERT, CHRISTINA, MOOE, THOMAS, DELLBORG, MIKAEL, TORSTENSSON, INGEMAR, ALBERTSSON, PER, JOHANSSON, LARS, AL-KHALILI, FARIS, ALMROTH, HENRIK, ANDERSSON, TOMMY, PANTEV, EMIL, TENGMARK, BENGT-OLOV, LIU, BO, RASMANIS, GUNDARS, WAHLGREN, CARL-MAGNUS, MOCCETTI, TIZIANO, PARKHOMENKO, ALEXANDER, TSELUYKO, VIRA, VOLKOV, VOLODYMYR, KOVAL, OLENA, KONONENKO, LYUDMYLA, PROKHOROV, OLEKSANDR, VDOVYCHENKO, VALERIY, BAZYLEVYCH, ANDRIY, RUDENKO, LEONID, VIZIR, VADYM, KARPENKO, OLEKSANDR, MALYNOVSKY, YAROSLAV, KOVAL, VALENTYNA, STOROZHUK, BORYS, COTTON, JAMES, VENKATARAMAN, ASOK, MORIARTY, ANDREW, CONNOLLY, DEREK, DAVEY, PATRICK, SENIOR, ROXY, BIRDI, INDERPAUL, CALVERT, JOHN, DONNELLY, PATRICK, TREVELYAN, JASPER, CARTER, JUSTIN, PEACE, AARON, AUSTIN, DAVID, KUKREJA, NEVILLE, HILTON, THOMAS, SRIVASTAVA, SUNNY, WALSH, RONALD, FIELDS, RONALD, HAKAS, JOSEPH, PORTNAY, EDWARD, GOGIA, HARINDER, SALACATA, ABRAHAM, HUNTER, JOHN J., BACHARACH, J MICHAEL, SHAMMAS, NICOLAS, SURESH, DAMODHAR, SCHNEIDER, RICKY, GURBEL, PAUL, BANERJEE, SUBHASH, GRENA, PAUL, BEDWELL, NOEL, SLOAN, STEPHEN, LUPOVITCH, STEVEN, SONI, ANAND, GIBSON, KATHLEEN, SANGRIGOLI, RENEE, MEHTA, RAJENDRA, I-HSUAN TSAI, PETER, GILLESPIE, EVE, DEMPSEY, STEPHEN, HAMROFF, GLENN, BLACK, ROBERT, LADER, ELLIS, KOSTIS, JOHN B., BITTNER, VERA, MCGUINN, WILLIAM, BRANCH, KELLEY, MALHOTRA, VINAY, MICHAELSON, STEPHEN, VACANTE, MICHAEL, MCCORMICK, MATTHEW, ARIMIE, RALUCA, CAMP, ALAN, DAGHER, GEORGE, KOSHY, N. MATHEW, THEW, STEPHEN, COSTELLO, FREDERICK, HEIMAN, MARK, CHILTON, ROBERT, MORAN, MICHAEL, ADLER, FREDRIC, COMEROTA, ANTHONY, SEIWERT, ANDREW, FRENCH, WILLIAM, SEROTA, HARVEY, HARRISON, ROBERT, BAKAEEN, FAISAL, OMER, SHUAB, CHANDRA, LOKESH, WHELAN, ALAN, BOYLE, ANDREW, ROBERTS-THOMSON, PHILIP, ROGERS, JAMES, CARROLL, PATRICK, COLQUHOUN, DAVID, SHAW, JAMES, BLOMBERY, PETER, AMERENA, JOHN, HII, CHRIS, ROYSE, ALISTAIR, SINGH, BHUWAN, SELVANAYAGAM, JOSEPH, JANSEN, SHIRLEY, LO, WINGCHI, HAMMETT, CHRISTOPHER, POULTER, ROHAN, NARASIMHAN, SESHASAYEE, WIGGERS, HENRIK, NIELSEN, HENRIK, GISLASON, GUNNAR, KOBER, LARS, HOULIND, KIM, BOENELYKKE SOERENSEN, VIBEKE, DIXEN, ULRIK, REFSGAARD, JENS, ZEUTHEN, ELISABETH, SOEGAARD, PETER, HRANAI, MARIAN, GASPAR, LUDOVIT, PELLA, DANIEL, HATALOVA, KATARINA, DROZDAKOVA, ERIKA, COMAN, IOAN, DIMULESCU, DOINA, VINEREANU, DRAGOS, CINTEZA, MIRCEA, SINESCU, CRINA, ARSENESCU, CATALINA, BENEDEK, IMRE, BOBESCU, ELENA, DOBREANU, DAN, GAITA, DAN, IANCU, ADRIAN, ILIESIU, ADRIANA, LIGHEZAN, DANIEL, PETRESCU, LUCIAN, PIRVU, OCTAVIAN, TEODORESCU, IULIA, TESLOIANU, DAN, VINTILA, MARIUS MARCIAN, CHIONCEL, OVIDIU, Anand, Sonia S, Bosch, Jackie, Eikelboom, John W, Connolly, Stuart J, Diaz, Rafael, Widimsky, Peter, Aboyans, Victor, Alings, Marco, Kakkar, Ajay K, Keltai, Katalin, Maggioni, Aldo P, Lewis, Basil S, Störk, Stefan, Zhu, Jun, Lopez-Jaramillo, Patricio, O'Donnell, Martin, Commerford, Patrick J, Vinereanu, Dragos, Pogosova, Nana, Ryden, Lars, Fox, Keith A A, Bhatt, Deepak L, Misselwitz, Frank, Varigos, John D, Vanassche, Thomas, Avezum, Alvaro A, Chen, Edmond, Branch, Kelley, Leong, Darryl P, Bangdiwala, Shrikant I, Hart, Robert G, and Yusuf, Salim
- Published
- 2018
- Full Text
- View/download PDF
67. Rationale and Design of a Prospective, Multicenter, Observational Study Evaluating Iron Deficiency in Patients Hospitalized for Heart Failure (FERIC-RO)
- Author
-
Antohi Elena Laura, Chitoiu Gabriel Tatu, Ambrosy Andrew P, Coman Ioan M, Vinereanu Dragos, Collins Sean P, Sinescu Crina, Mihaileanu Serban, Pang Peter S, Butler Javed, and Chioncel Ovidiu
- Subjects
heart failure ,iron deficiency ,clinical studies ,Medicine - Abstract
Introduction: Several landmark studies, which enrolled heart failure (HF) patients who were ambulatory at the time of inclusion, identified iron deficiency (ID) as an important therapeutic target: intravenous iron administration with ferric carboxymaltose (FCM) improves morbidity, exercise capacity, and quality of life in patients with HF and reduced EF (HFrEF). However, there is still limited knowledge about ID prevalence during hospitalization for Worsening Chronic HF (WCHF) and about the relationship between ID during hospitalization and post-discharge outcomes. Although previous studies documented ID as an independent risk factor for poor outcomes in HFrEF, its prognostic significance in HF patients with EF>40% remains unclear.
- Published
- 2018
- Full Text
- View/download PDF
68. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies
- Author
-
Polovina, Marija, primary, Tschöpe, Carsten, additional, Rosano, Giuseppe, additional, Metra, Marco, additional, Crea, Filippo, additional, Mullens, Wilfried, additional, Bauersachs, Johann, additional, Sliwa, Karen, additional, de Boer, Rudolf A., additional, Farmakis, Dimitrios, additional, Thum, Thomas, additional, Corrado, Domenico, additional, Bayes‐Genis, Antoni, additional, Bozkurt, Biykem, additional, Filippatos, Gerasimos, additional, Keren, Andre, additional, Skouri, Hadi, additional, Moura, Brenda, additional, Volterrani, Maurizio, additional, Abdelhamid, Magdy, additional, Ašanin, Milika, additional, Krljanac, Gordana, additional, Tomić, Milenko, additional, Savarese, Gianluigi, additional, Adamo, Marianna, additional, Lopatin, Yuri, additional, Chioncel, Ovidiu, additional, Coats, Andrew J.S., additional, and Seferović, Petar M., additional
- Published
- 2023
- Full Text
- View/download PDF
69. LEFT VENTRICULAR EJECTION FRACTION DIGIT BIAS AND RECLASSIFICATION OF HEART FAILURE WITH MILDLY REDUCED VS. REDUCED EJECTION FRACTION BASED ON THE 2021 DEFINITION AND CLASSIFICATION OF HEART FAILURE
- Author
-
Savarese, Gianluigi, primary, Gatti, Paolo, additional, Benson, Lina, additional, Adamo, Marianna, additional, Chioncel, Ovidiu, additional, Crespo-Leiro, Maria G., additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Filippatos, Gerasimos, additional, Lainscak, Mitja, additional, McDonagh, Theresa, additional, Mebazaa, Alexandre, additional, Metra, Marco, additional, Piepoli, Massimo F., additional, Rosano, Giuseppe M.C., additional, Ruschitzka, Frank, additional, Seferovic, Petar, additional, Volterrani, Maurizio, additional, Maggioni, Aldo P., additional, and und, Lars, additional
- Published
- 2023
- Full Text
- View/download PDF
70. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
- Author
-
TOMASONI, DANIELA, primary, DAVISON, BETH, additional, ADAMO, MARIANNA, additional, PAGNESI, MATTEO, additional, MEBAZAA, ALEXANDRE, additional, EDWARDS, CHRISTOPHER, additional, ARRIGO, MATTIA, additional, BARROS, MARIANELA, additional, BIEGUS, JAN, additional, ČELUTKIENĖ, JELENA, additional, ČERLINSKAITĖ-BAJORĖ, KAMILĖ, additional, CHIONCEL, OVIDIU, additional, COHEN-SOLAL, ALAIN, additional, DAMASCENO, ALBERTINO, additional, DIAZ, RAFAEL, additional, FILIPPATOS, GERASIMOS, additional, GAYAT, ETIENNE, additional, KIMMOUN, ANTOINE, additional, LAM, CAROLYN S.P., additional, NOVOSADOVA, MARIA, additional, PANG, PETER S., additional, PONIKOWSKI, PIOTR, additional, SAIDU, HADIZA, additional, SLIWA, KAREN, additional, TAKAGI, KOJI, additional, MAATEN, JOZINE M. TER, additional, VOORS, ADRIAAN, additional, COTTER, GAD, additional, and METRA, MARCO, additional
- Published
- 2023
- Full Text
- View/download PDF
71. State‐of‐the‐art document on optimal contemporary management of cardiomyopathies
- Author
-
Seferović, Petar M., primary, Polovina, Marija, additional, Rosano, Giuseppe, additional, Bozkurt, Biykem, additional, Metra, Marco, additional, Heymans, Stephane, additional, Mullens, Wilfried, additional, Bauersachs, Johann, additional, Sliwa, Karen, additional, de Boer, Rudolf A., additional, Farmakis, Dimitrios, additional, Thum, Thomas, additional, Olivotto, Iacopo, additional, Rapezzi, Claudio, additional, Linhart, Aleš, additional, Corrado, Domenico, additional, Tschöpe, Carsten, additional, Milinković, Ivan, additional, Bayes Genis, Antoni, additional, Filippatos, Gerasimos, additional, Keren, Andre, additional, Ašanin, Milika, additional, Krljanac, Gordana, additional, Maksimović, Ružica, additional, Skouri, Hadi, additional, Ben Gal, Tuvia, additional, Moura, Brenda, additional, Volterrani, Maurizio, additional, Abdelhamid, Magdy, additional, Lopatin, Yuri, additional, Chioncel, Ovidiu, additional, and Coats, Andrew J.S., additional
- Published
- 2023
- Full Text
- View/download PDF
72. Noncardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG‐HF trial
- Author
-
Chioncel, Ovidiu, primary, Davison, Beth, additional, Adamo, Marianna, additional, Antohi, Laura E, additional, Arrigo, Mattia, additional, Barros, Marianela, additional, Biegus, Jan, additional, Čerlinskaitė‐Bajorė, Kamilė, additional, Celutkiene, Jelena, additional, Cohen‐Solal, Alain, additional, Damasceno, Albertino, additional, Diaz, Rafael, additional, Edwards, Christopher, additional, Filippatos, Gerasimos, additional, Kimmoun, Antoine, additional, Lam, Carolyn S.P., additional, Metra, Marco, additional, Novosadova, Maria, additional, Pagnesi, Matteo, additional, Pang, Peter S., additional, Ponikowski, Piotr, additional, Radu, Razvan I, additional, Saidu, Hadiza, additional, Sliwa, Karen, additional, Voors, Adriaan A., additional, Takagi, Koji, additional, Ter Maaten, Jozine M., additional, Tomasoni, Daniela, additional, Cotter, Gad, additional, and Mebazaa, Alexandre, additional
- Published
- 2023
- Full Text
- View/download PDF
73. Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT‐proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC
- Author
-
Bayes‐Genis, Antoni, primary, Doherty, Kieran F, additional, Petrie, Mark C, additional, Januzzi, James L, additional, Mueller, Christian, additional, Andreson, Lisa, additional, Bozkurt, Biykem, additional, Butler, Javed, additional, Chioncel, Ovidiu, additional, Cleland, John GF, additional, Christodorescu, Ruxandra, additional, Del Prato, Stefano, additional, Gustafsson, Finn, additional, Lam, Carolyn S.P., additional, Moura, Brenda, additional, Pop‐Busui, Rodica, additional, Seferovic, Petar, additional, Volterrani, Maurizio, additional, Vaduganathan, Muthiah, additional, Metra, Marco, additional, and Rosano, Giuseppe, additional
- Published
- 2023
- Full Text
- View/download PDF
74. Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians
- Author
-
Vazir, Ali, primary, Kapelios, Chris J., additional, Agaoglu, Elif, additional, Metra, Marco, additional, Lopatin, Yury, additional, Seferovic, Petar, additional, Mullens, Wilfred, additional, Filippatos, Gerasimos, additional, Rosano, Giuseppe, additional, Coats, Andrew J.S., additional, and Chioncel, Ovidiu, additional
- Published
- 2023
- Full Text
- View/download PDF
75. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
- Author
-
Carbajales, Justo, Gómez, Javier Neri Ceferino, Principato, Mario Bruno, Von Wulffen, María Alejandra, Acunzo, Jorge Galperín Rafael Salvador, Bonato, Ricardo Renato, Ciampi, Natalia, Marani, Alberto Babil, Panigadi, Cristian Gustavo, Pastura, Silvia Gabriela, Onetto, Leonardo Martín, Moya, Cecilia Rafaela, Budassi, Nadia, Valle, Marisol, Camerini, Daniel, Monjes, Enrique, Zabala, Federico, Ricart, Juan Pablo, Medesani, Luis, Campos, Eduardo Noe Ortuño, Ferroni, Fabián, Torres, Mariana Foa, Fassi, Daniel Omar, Bosio, Fernando Javier Díaz, Baztarrica, Gabriel Edgardo Pérez, Infantas, Teresa Zúñiga, Perlo, Daniela, García, Celso Fernando, Durán, Rubén García, Durán, Luisina García, Pettinari, Cecilia Alejandra, Vico, Marisa Liliana, Lanchiotti, Paulina Virginia, Gómez, Mariela Soledad, Poy, Carlos Alberto, Grazziani, Franco Sebastián, Laspina, Marcela Julieta, Poy, María Laura, Bahit, María Cecilia, Tajer, Carlos, García, Marilia, Lopes, Renato D., de Barros e Silva, Pedro Gabriel Melo, Berwanger, Otavio, Egydio, Flávia, Restelli, Elissa, Kawakami, Anelise, Soares, Tamara Colaiácovo, Valois, Mayara Vioto, Duarte, Tauane Bello, Barbosa, Lilian Mazza, de Paola, Angelo Amato Vicenzo, Pimenta, Thiago Librelon, Jeronimo, Gabriela Dal Moro, da Costa, Bruna S. Fernandes, Coutinho, Enia Lucia, Guerrero, Andressa Zulmira A., Maia, Lilia Nigro, Nakazone, Marcelo Arruda, Lemos, Maria Angelica Teixeira, Costa, Osana Maria Coelho, Demore, Ana Paula, Brito, Roberta Parra, Melo, Camila Dal Bon, Góes, Nadielly Codonho, Lorenço, Osvaldo, Gonçalves, Luiz Otavio Maia, Nishiama, Kátia, de Lima, Tiago Aparecido Maschio, Backes, Luciano Marcelo, de Lima Deucher, Keyla Liliana Alves, Rodrigues, Milena Pozzatto, Baldissera, Dunnia Monisa, Reolão, José Basileu Caos, dos Santos, Tais Alves, Freisleben, Fernanda Michel Birck, da Silveira Kaross, Níncia Lucca, Montovani, Jéssika Tzervieczenski, Cantarelli, Maiara, Lucion, Aline, do Amarante, Luciano, Foscarini, Priscila, de Mello Perez, Claudia, França, Fernanda Ribeiro, Fialho, Lisa, Rey, Helena Cramer Veiga, God, Epotamenides Maria Good, Figueiredo, Estêvão Lanna, Werner, Gustavo Fonseca, de Faria Garcia, Jose Carlos, Azevedo, Bruna, Barbosa, Luiz Carlos Vianna, Pardi, Ernaldo, Oliveira, Márcia Domingos, Martinelli, Toshie, Cavalini, Roseli Gomes, de Moraes, Michele Santos Montoni, Filho, Adalberto Menezes Lorga, Palmegiani, Eduardo, Megid, Thiago Baccilli Cury, Queirantes, Clotildes S.P., Cruz, Thamyres Santini Arroyo, He, Pengkang, Zhou, Xiaolan, Zhou, Na, Zhao, Mingzhong, Yu, Juan, Cheng, Yong, Wang, Lijun, Liu, Lili, Liu, Shuwang, Li, Lei, Li, Aihua, Yuan, Xiaochen, Xia, Guangwei, Wang, Zhirong, Li, Chengzong, Chen, Wensu, Tang, Qiang, Tang, Qunzhong, Xu, Weiting, Zhu, Xinyi, Hou, Bin, Ma, Wenjian, Wang, Chongquan, Jin, Qiaoyun, Wang, Jianan, Xie, Xiaojie, Joseph, Johny, Davidson, Deepak, Thomas, Joby K., Kunjumon, Tony V., Stephen, Tibin, Fatania, Kamlesh, Rathi, Gaurav, Garala, Kinjal, Doshi, Dhruval, Varghese, Kiron, MA, Srilakshmi, Sheeba, Lumin, Kumar, Shantha, Rao, Malipeddi Bhaskara, Rao, Kodem Damodara, Vuriya, Anjan Kumar, Kumari, Mandula Padma, Khandelwal, Bidita, Dhakal, Mona, Srivastava, Nitin, Khatri, Dheeraj, Moktan, Shova, Gupta, Rajeev, Roy, Sanjeeb, Kumawat, Kapil, Sharma, Mukesh, Sharma, K.K., Jathappa, Narendra, Lokesh, B.H., Kariyappa, Shilpa, Leela, A.C., Someshwara, K.C., Desai, Soaham, Desai, Devangi, Patel, Kunj, Patel, Sujal, Bhartiya, Maulik, Mahanta, Bhupendra Narayan, Dutta, Dibya Jyoti, Rajkonwer, Ghanashyam, Gupta, Sandeep Kumar, Mishra, Ashok Kumar, Singh, Akansha, Kesarwani, Naveen, Kumar, Shivendra, Chioncel, Ovidiu, Balan, Adriana, Carstea, Nicolae, Chitoiu, Gabriel Tatu, Cornaciu, Stelian, Cinteza, Mircea, Rimbas, Roxana C., Dimulescu, Doina, Ionescu, Luminita, Fruntelata, Ana, Dumitru, Nicoleta, Gaita, Dan, Pleava, Roxana, Iliesiu, Adriana, Uscoiu, Gabriela, Lighezan, Daniel, Buzas, Roxana, Sinescu, Crina J., Avram, Ana-Maria, Baldea, Sorina, Galrinho, Ruxandra Dragoi, Magda, Stefania L., Matei, Lavinia, Vinereanu, Dragos, Lopes, Renato D, Bahit, M Cecilia, Xavier, Denis, Jiang, Jie, Al-Khalidi, Hussein R, He, Wensheng, Xian, Ying, Ciobanu, Andrea O, Kamath, Deepak Y, Fox, Kathleen A, Rao, Meena P, Pokorney, Sean D, de Barros e Silva, Pedro G M, Roettig, Mayme L, Huo, Yong, and Granger, Christopher B
- Published
- 2017
- Full Text
- View/download PDF
76. Microcirculatory Dysfunction in Acute Heart Failure
- Author
-
Chioncel, Ovidiu, primary and Mebazaa, Alexandre, additional
- Published
- 2019
- Full Text
- View/download PDF
77. Expanded algorithm for managing patients with acute decompensated heart failure
- Author
-
Njoroge, Joyce N., Cheema, Baljash, Ambrosy, Andrew P., Greene, Stephen J., Collins, Sean P., Vaduganathan, Muthiah, Mebazaa, Alexandre, Chioncel, Ovidiu, Butler, Javed, and Gheorghiade, Mihai
- Published
- 2018
- Full Text
- View/download PDF
78. Addressing Comorbidities in Heart Failure: When Feeling Better and Living Longer Go in the Same Direction
- Author
-
Chioncel, Ovidiu, primary, Tomasoni, Daniela, additional, and Metra, Marco, additional
- Published
- 2023
- Full Text
- View/download PDF
79. ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases
- Author
-
Coisne, Augustin, primary, Lancellotti, Patrizio, additional, Habib, Gilbert, additional, Garbi, Madalina, additional, Dahl, Jordi Sanchez, additional, Barbanti, Marco, additional, Vannan, Mani A., additional, Vassiliou, Vassilios S., additional, Dudek, Dariusz, additional, Chioncel, Ovidiu, additional, Waltenberger, Johannes L., additional, Johnson, Victoria L., additional, De Paulis, Ruggero, additional, Citro, Rodolfo, additional, and Pibarot, Philippe, additional
- Published
- 2023
- Full Text
- View/download PDF
80. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
- Author
-
Anker, Stefan D., primary, Usman, Muhammad Shariq, additional, Anker, Markus S., additional, Butler, Javed, additional, Böhm, Michael, additional, Abraham, William T., additional, Adamo, Marianna, additional, Chopra, Vijay K., additional, Cicoira, Mariantonietta, additional, Cosentino, Francesco, additional, Filippatos, Gerasimos, additional, Jankowska, Ewa A., additional, Lund, Lars H., additional, Moura, Brenda, additional, Mullens, Wilfried, additional, Pieske, Burkert, additional, Ponikowski, Piotr, additional, Gonzalez‐Juanatey, Jose R., additional, Rakisheva, Amina, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Teerlink, John R., additional, Tschöpe, Carsten, additional, Volterrani, Maurizio, additional, von Haehling, Stephan, additional, Zhang, Jian, additional, Zhang, Yuhui, additional, Bauersachs, Johann, additional, Landmesser, Ulf, additional, Zieroth, Shelley, additional, Tsioufis, Konstantinos, additional, Bayes‐Genis, Antoni, additional, Chioncel, Ovidiu, additional, Andreotti, Felicita, additional, Agabiti‐Rosei, Enrico, additional, Merino, Jose L., additional, Metra, Marco, additional, Coats, Andrew J.S., additional, and Rosano, Giuseppe M.C., additional
- Published
- 2023
- Full Text
- View/download PDF
81. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC‐HFA Heart Failure Long‐Term Registry
- Author
-
Adamo, Marianna, primary, Chioncel, Ovidiu, additional, Benson, Lina, additional, Shahim, Bahira, additional, Crespo‐Leiro, Maria G., additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Filippatos, Gerasimos, additional, Lainscak, Mitja, additional, McDonagh, Theresa, additional, Mebazaa, Alexander, additional, Piepoli, Massimo F., additional, Rosano, Giuseppe M.C., additional, Ruschitzka, Frank, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Shahim, Angiza, additional, Popescu, Bogdan A., additional, Iung, Bernard, additional, Volterrani, Maurizio, additional, Maggioni, Aldo P., additional, Metra, Marco, additional, and Lund, Lars H., additional
- Published
- 2023
- Full Text
- View/download PDF
82. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
- Author
-
Chioncel, Ovidiu, primary, Adamo, Marianna, additional, Nikolaou, Maria, additional, Parissis, John, additional, Mebazaa, Alexandre, additional, Yilmaz, Mehmet Birhan, additional, Hassager, Christian, additional, Moura, Brenda, additional, Bauersachs, Johann, additional, Harjola, Veli‐Pekka, additional, Antohi, Elena‐Laura, additional, Ben‐Gal, Tuvia, additional, Collins, Sean P., additional, Iliescu, Vlad Anton, additional, Abdelhamid, Magdy, additional, Čelutkienė, Jelena, additional, Adamopoulos, Stamatis, additional, Lund, Lars H., additional, Cicoira, Mariantonietta, additional, Masip, Josep, additional, Skouri, Hadi, additional, Gustafsson, Finn, additional, Rakisheva, Amina, additional, Ahrens, Ingo, additional, Mortara, Andrea, additional, Janowska, Ewa A., additional, Almaghraby, Abdallah, additional, Damman, Kevin, additional, Miro, Oscar, additional, Huber, Kurt, additional, Ristic, Arsen, additional, Hill, Loreena, additional, Mullens, Wilfried, additional, Chieffo, Alaide, additional, Bartunek, Jozef, additional, Paolisso, Pasquale, additional, Bayes‐Genis, Antoni, additional, Anker, Stefan D., additional, Price, Susanna, additional, Filippatos, Gerasimos, additional, Ruschitzka, Frank, additional, Seferovic, Petar, additional, Vidal‐Perez, Rafael, additional, Vahanian, Alec, additional, Metra, Marco, additional, McDonagh, Theresa A., additional, Barbato, Emanuele, additional, Coats, Andrew J.S., additional, and Rosano, Giuseppe M.C., additional
- Published
- 2023
- Full Text
- View/download PDF
83. Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction
- Author
-
Pagnesi, Matteo, primary, Metra, Marco, additional, Cohen-Solal, Alain, additional, Edwards, Christopher, additional, Adamo, Marianna, additional, Tomasoni, Daniela, additional, Lam, Carolyn S.P., additional, Chioncel, Ovidiu, additional, Diaz, Rafael, additional, Filippatos, Gerasimos, additional, Ponikowski, Piotr, additional, Sliwa, Karen, additional, Voors, Adriaan A., additional, Kimmoun, Antoine, additional, Novosadova, Maria, additional, Takagi, Koji, additional, Barros, Marianela, additional, Damasceno, Albertino, additional, Saidu, Hadiza, additional, Gayat, Etienne, additional, Pang, Peter S., additional, Celutkiene, Jelena, additional, Cotter, Gad, additional, Mebazaa, Alexandre, additional, and Davison, Beth, additional
- Published
- 2023
- Full Text
- View/download PDF
84. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure
- Author
-
Vaduganathan, Muthiah, Marti, Catherine N., Mentz, Robert J., Greene, Stephen J., Ambrosy, Andrew P., Subacius, Haris P., Fonarow, Gregg C., Chioncel, Ovidiu, Bazari, Hasan, Maggioni, Aldo P., Zannad, Faiez, Konstam, Marvin A., Sato, Naoki, Gheorghiade, Mihai, and Butler, Javed
- Published
- 2016
- Full Text
- View/download PDF
85. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
- Author
-
Metra, Marco, Tomasoni, Daniela, Adamo, Marianna, Bayes-Genis, Antoni, Filippatos, Gerasimos, Abdelhamid, Magdy, Adamopoulos, Stamatis, Anker, Stefan D, Antohi, Laura, Böhm, Michael, Braunschweig, Frieder, Gal, Tuvia Ben, Butler, Javed, Cleland, John G F, Cohen-Solal, Alain, Damman, Kevin, Gustafsson, Finn, Hill, Loreena, Jankowska, Ewa A, Lainscak, Mitja, Lund, Lars H, McDonagh, Theresa, Mebazaa, Alexandre, Moura, Brenda, Mullens, Wilfried, Piepoli, Massimo, Ponikowski, Piotr, Rakisheva, Amina, Ristic, Arsen, Savarese, Gianluigi, Seferovic, Petar, Sharma, Rajan, Tocchetti, Carlo Gabriele, Yılmaz, Mehmet Birhan, Vitale, Cristiana, Volterrani, Maurizio, von Haehling, Stephan, Chioncel, Ovidiu, Coats, Andrew J S, Rosano, Giuseppe, Metra, Marco, Tomasoni, Daniela, Adamo, Marianna, Bayes-Genis, Antoni, Filippatos, Gerasimo, Abdelhamid, Magdy, Adamopoulos, Stamati, Anker, Stefan D, Antohi, Laura, Böhm, Michael, Braunschweig, Frieder, Gal, Tuvia Ben, Butler, Javed, Cleland, John G F, Cohen-Solal, Alain, Damman, Kevin, Gustafsson, Finn, Hill, Loreena, Jankowska, Ewa A, Lainscak, Mitja, Lund, Lars H, Mcdonagh, Theresa, Mebazaa, Alexandre, Moura, Brenda, Mullens, Wilfried, Piepoli, Massimo, Ponikowski, Piotr, Rakisheva, Amina, Ristic, Arsen, Savarese, Gianluigi, Seferovic, Petar, Sharma, Rajan, Tocchetti, Carlo Gabriele, Yılmaz, Mehmet Birhan, Vitale, Cristiana, Volterrani, Maurizio, von Haehling, Stephan, Chioncel, Ovidiu, Coats, Andrew J S, and Rosano, Giuseppe
- Subjects
Hospitalization ,Emergency department visits ,Intensification of oral therapy ,Outpatients ,Prognosis ,Worsening heart failure ,Prognosi ,Outpatient ,Emergency department visit ,Cardiology and Cardiovascular Medicine - Abstract
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
- Published
- 2023
86. Optimizing outcomes in heart failure: 2022 and beyond
- Author
-
Jankowska, Ewa A., Andersson, Tomas, Kaiser-Albers, Claudia, Bozkurt, Biykem, Chioncel, Ovidiu, Coats, Andrew J. S., Hill, Loreena, Koehler, Friedrich, Lund, Lars H., McDonagh, Theresa, Metra, Marco, Mittmann, Clemens, MULLENS, Wilfried, Siebert, Uwe, Solomon, Scott D., Volterrani, Maurizio, McMurray, John J. V., Jankowska, Ewa A., Andersson, Tomas, Kaiser-Albers, Claudia, Bozkurt, Biykem, Chioncel, Ovidiu, Coats, Andrew J. S., Hill, Loreena, Koehler, Friedrich, Lund, Lars H., McDonagh, Theresa, Metra, Marco, Mittmann, Clemens, MULLENS, Wilfried, Siebert, Uwe, Solomon, Scott D., Volterrani, Maurizio, and McMurray, John J. V.
- Subjects
Multidisciplinary management ,Heart failure ,Medical decision making ,Quality improvement ,Health technology assessment ,Clinical practice guidelines ,Pharmacotherapy - Abstract
Although the development of therapies and tools for the improved management of heart failure (HF) continues apace, day-to-day management in clinical practice is often far from ideal. A Cardiovascular Round Table workshop was convened by the European Society of Cardiology (ESC) to identify barriers to the optimal implementation of therapies and guidelines and to consider mitigation strategies to improve patient outcomes in the future. Key challenges identified included the complexity of HF itself and its treatment, financial constraints and the perception of HF treatments as costly, failure to meet the needs of patients, suboptimal outpatient management, and the fragmented nature of healthcare systems. It was discussed that ongoing initiatives may help to address some of these barriers, such as changes incorporated into the 2021 ESC HF guideline, ESC Heart Failure Association quality indicators, quality improvement registries (e.g. EuroHeart), new ESC guidelines for patients, and the universal definition of HF. Additional priority action points discussed to promote further improvements included revised definitions of HF 'phenotypes' based on trial data, the development of implementation strategies, improved affordability, greater regulator/payer involvement, increased patient education, further development of patient-reported outcomes, better incorporation of guidelines into primary care systems, and targeted education for primary care practitioners. Finally, it was concluded that overarching changes are needed to improve current HF care models, such as the development of a standardized pathway, with a common adaptable digital backbone, decision-making support, and data integration, to ensure that the model 'learns' as the management of HF continues to evolve. This article was generated from discussions during a Cardiovascular Round Table workshop organized in September 2021 by the ESC. The ESC Cardiovascular Round Table is a strategic forum for high-level dialogue between 20 industry companies (pharmaceutical, devices, and diagnostics) and the ESC leadership to identify and discuss key strategic issues for the future of cardiovascular health in Europe. The authors would like to thank Emma Marshman [unaffiliated, supported by the European Society of Cardiology (ESC)] for assistance writing and editing the manuscript
- Published
- 2023
87. Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC-HFA EORP Heart Failure Long-Term Registry
- Author
-
Kaplon-Cieslicka, Agnieszka, Benson, Lina, Chioncel, Ovidiu, Crespo-Leiro, María Generosa, Coats, Andrew J.S., Anker, Stefan, Ruschitzka, Frank, Hage, Camilla, Drozdz, Jaroslaw, Seferovic, Petar, Rosano, Giuseppe, Piepoli, Massimo, Mebazaa, Alexandre, McDonagh, Theresa, Lainscak, Mitja, Savarese, Gianluigi, Ferrari, Roberto, Mullens, Wilfried, Bayes-Genis, Antoni, Maggioni, Aldo P., Lund, Lars H., Maggioni, Aldo Pietro/0000-0003-2764-6779, Mirrakhimov, Erkin/0000-0003-2982-6108, Gale, Chris/0000-0003-4732-382X, Kaplon-Cieslicka, Agnieszka, Benson, Lina, Chioncel, Ovidiu G., Crespo-Leiro, Maria, Coats, Andrew J. S. D., Anker, Stefan, Ruschitzka, Frank, Hage, Camilla, Drozdz, Jaroslaw, Seferovic, Petar, Rosano, Giuseppe M. C., Piepoli, Massimo, Mebazaa, Alexandre, McDonagh, Theresa, Lainscak, Mitja, Savarese, Gianluigi, Ferrari, Roberto, MULLENS, Wilfried, Bayes-Genis, Antoni P., Maggioni, Aldo H., and Lund, Lars
- Subjects
Hyponatraemia ,Sodium ,Worsening heart failure ,Congestion ,Acute heart failure ,Prognosis - Abstract
Aims To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post-discharge outcomes. Methods and results Of 8298 patients in the European Society of Cardiology Heart Failure Long-Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium
- Published
- 2023
88. Definition, epidemiology, and burden of disease: HFrEF
- Author
-
Maggioni, Aldo Pietro, primary and Chioncel, Ovidiu, additional
- Published
- 2018
- Full Text
- View/download PDF
89. Therapeutic Advances in the Management of Cardiogenic Shock
- Author
-
Chioncel, Ovidiu, Collins, Sean P., Ambrosy, Andrew P., Pang, Peter S., Radu, Razvan I., Antohi, Elena-Laura, Masip, Josep, Butler, Javed, and Iliescu, Vlad Anton
- Published
- 2019
- Full Text
- View/download PDF
90. Therapeutic Advances in the Management of Acute Decompensated Heart Failure
- Author
-
Antohi, Elena-Laura, Ambrosy, Andrew P., Collins, Sean P., Ahmed, Ali, Iliescu, Vlad Anton, Cotter, Gad, Pang, Peter S., Butler, Javed, and Chioncel, Ovidiu
- Published
- 2019
- Full Text
- View/download PDF
91. Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
- Author
-
Metra, Marco, Adamo, Marianna, Tomasoni, Daniela, Mebazaa, Alexandre, Bayes-Genis, Antoni, Abdelhamid, Magdy, Adamopoulos, Stamatis, Anker, Stefan D., Bauersachs, Johann, Belenkov, Yuri, Boehm, Michael, Gal, Tuvia Ben, Butler, Javed, Cohen-Solal, Alain, Filippatos, Gerasimos, Gustafsson, Finn, Hill, Loreena, Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lopatin, Yuri, Lund, Lars H., McDonagh, Theresa, Milicic, Davor, Moura, Brenda, Mullens, Wilfried, Piepoli, Massimo, Polovina, Marija, Ponikowski, Piotr, Rakisheva, Amina, Ristic, Arsen, Savarese, Gianluigi, Seferovic, Petar, Sharma, Rajan, Thum, Thomas, Tocchetti, Carlo G., Van Linthout, Sophie, Vitale, Cristiana, Von Haehling, Stephan, Volterrani, Maurizio, Coats, Andrew J. S., Chioncel, Ovidiu, Rosano, Giuseppe, Metra, Marco, Adamo, Marianna, Tomasoni, Daniela, Mebazaa, Alexandre, Bayes-Genis, Antoni, Abdelhamid, Magdy, Adamopoulos, Stamatis, Anker, Stefan D., Bauersachs, Johann, Belenkov, Yuri, Boehm, Michael, Gal, Tuvia Ben, Butler, Javed, Cohen-Solal, Alain, Filippatos, Gerasimos, Gustafsson, Finn, Hill, Loreena, Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lopatin, Yuri, Lund, Lars H., McDonagh, Theresa, Milicic, Davor, Moura, Brenda, Mullens, Wilfried, Piepoli, Massimo, Polovina, Marija, Ponikowski, Piotr, Rakisheva, Amina, Ristic, Arsen, Savarese, Gianluigi, Seferovic, Petar, Sharma, Rajan, Thum, Thomas, Tocchetti, Carlo G., Van Linthout, Sophie, Vitale, Cristiana, Von Haehling, Stephan, Volterrani, Maurizio, Coats, Andrew J. S., Chioncel, Ovidiu, and Rosano, Giuseppe
- Abstract
Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked increases in death and rehospitalization rates, which then decline exponentially though they remain higher than in patients without a recent hospitalization. Therefore, optimal management of patients with acute heart failure before discharge and in the early post-discharge phase is critical. First, it may prevent rehospitalizations through the early detection and effective treatment of residual or recurrent congestion, the main manifestation of decompensation. Second, initiation at pre-discharge and titration to target doses in the early post-discharge period, of guideline-directed medical therapy may improve both short- and long-term outcomes. Third, in chronic heart failure, medical treatment is often left unchanged, so the acute heart failure hospitalization presents an opportunity for implementation of therapy. The aim of this scientific statement by the Heart Failure Association of the European Society of Cardiology is to summarize recent findings that have implications for clinical management both in the pre-discharge and the early post-discharge phase after a hospitalization for acute heart failure.
- Published
- 2023
- Full Text
- View/download PDF
92. Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
- Author
-
Lund, Lars H., Crespo-Leiro, María Generosa, Laroche, Cecile, García-Pinilla, José M., Bennis, Ahmed, Vataman, Eleonora B., Polovina, Marija, Radovanovic, Slavica, Apostolovic, Svetlana R., Asanin, Milika, Gackowski, Andrzej, Kaplon-Cieslicka, Agnieszka, Cabac-Pogorevici, Irina, Anker, Stefan D., Chioncel, Ovidiu, Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, Mcdonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo, Rosano, Giuseppe M., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar, Lung, Bernard, Popescu, Bogdan A., Maggioni, Aldo P., Lund, Lars H., Crespo-Leiro, María Generosa, Laroche, Cecile, García-Pinilla, José M., Bennis, Ahmed, Vataman, Eleonora B., Polovina, Marija, Radovanovic, Slavica, Apostolovic, Svetlana R., Asanin, Milika, Gackowski, Andrzej, Kaplon-Cieslicka, Agnieszka, Cabac-Pogorevici, Irina, Anker, Stefan D., Chioncel, Ovidiu, Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, Mcdonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo, Rosano, Giuseppe M., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar, Lung, Bernard, Popescu, Bogdan A., and Maggioni, Aldo P.
- Abstract
[Abstract] Aims: Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries. Methods: Between 1 November 2018 and 31 December 2020, 10 162 patients with chronic or acute/worsening HF with reduced, mildly reduced, or preserved ejection fraction were enrolled from 220 centres in 41 European or ESC affiliated countries. The ESC HF III Registry collected data on baseline characteristics (hospital or clinic presentation), hospital course, diagnostic and therapeutic decisions in hospital and at the clinic visit; and on outcomes at 12-month follow-up. These data include demographics, medical history, physical examination, biomarkers and imaging, quality of life, treatments, and interventions - including drug doses and reasons for non-use, and cause-specific outcomes. Conclusion: The ESC HF III Registry will provide comprehensive and unique insight into contemporary HF characteristics, treatment implementation, and outcomes, and may impact implementation strategies, clinical discovery, trial design, and public policy.
- Published
- 2023
93. Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure
- Author
-
Savarese, Gianluigi, Gatti, Paolo, Benson, Lina, Adamo, Marianna, Chioncel, Ovidiu, Crespo-Leiro, María Generosa, Anker, Stefan D., Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, Mcdonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo, Rosano, Giuseppe M., Ruschitzka, Frank, Seferovic, Petar, Volterrani, Maurizio, Maggioni, Aldo P., Lund, Lars H., Savarese, Gianluigi, Gatti, Paolo, Benson, Lina, Adamo, Marianna, Chioncel, Ovidiu, Crespo-Leiro, María Generosa, Anker, Stefan D., Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, Mcdonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo, Rosano, Giuseppe M., Ruschitzka, Frank, Seferovic, Petar, Volterrani, Maurizio, Maggioni, Aldo P., and Lund, Lars H.
- Abstract
[Abstract] Aims: Aims were to evaluate (1) reclassification of patients from heart failure with mildly reduced (HFmrEF) to reduced (HFrEF) ejection fraction when an EF = 40% was considered as HFrEF, (2) role of EF digit bias, ie, EF reporting favouring 5% increments; (3) outcomes in relation to missing and biased EF reports, in a large multinational HF registry. Methods and results: Of 25,154 patients in the European Society of Cardiology (ESC) HF Long-Term registry, 17% had missing EF and of those with available EF, 24% had HFpEF (EF≥50%), 21% HFmrEF (40%-49%) and 55% HFrEF (<40%) according to the 2016 ESC guidelines´ classification. EF was "exactly" 40% in 7%, leading to reclassifying 34% of the HFmrEF population defined as EF = 40% to 49% to HFrEF when applying the 2021 ESC Guidelines classification (14% had HFmrEF as EF = 41% to 49% and 62% had HFrEF as EF≤40%). EF was reported as a value ending with 0 or 5 in ∼37% of the population. Such potential digit bias was associated with more missing values for other characteristics and higher risk of all-cause death and HF hospitalization. Patients with missing EF had higher risk of all-cause and CV mortality, and HF hospitalization compared to those with recorded EF. Conclusions: Many patients had reported EF = 40%. This led to substantial reclassification of EF from old HFmrEF (40%-49%) to new HFrEF (≤40%). There was considerable digit bias in EF reporting and missing EF reporting, which appeared to occur not at random and may reflect less rigorous overall care and worse outcomes.
- Published
- 2023
94. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- Author
-
McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haram, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Crespo-Leiro, María Generosa, Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lam, Carolyn S.P., Lyon, Alexander R., McMurray, John J.V., Mebazaa, Alexandre, Mindham, Richard, Muneretto, Claudio, Piepoli, Massimo Francesco, Price, Susanna, Rosano, Giuseppe M.C., Ruschitzka, Frank, Skibelund, Anne Kathrine, McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haram, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Crespo-Leiro, María Generosa, Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, Lam, Carolyn S.P., Lyon, Alexander R., McMurray, John J.V., Mebazaa, Alexandre, Mindham, Richard, Muneretto, Claudio, Piepoli, Massimo Francesco, Price, Susanna, Rosano, Giuseppe M.C., Ruschitzka, Frank, and Skibelund, Anne Kathrine
- Published
- 2023
95. State-of-the-art document on optimal contemporary management of cardiomyopathies
- Author
-
Seferović, Petar M., Polovina, Marija, Rosano, Giuseppe, Bozkurt, Biykem, Metra, Marco, Heymans, Stephane, Mullens, Wilfried, Bauersachs, Johann, Sliwa, Karen, de Boer, Rudolf A., Farmakis, Dimitrios, Thum, Thomas, Olivotto, Iacopo, Rapezzi, Claudio, Linhart, Aleš, Corrado, Domenico, Tschöpe, Carsten, Milinković, Ivan, Bayes Genis, Antoni, Filippatos, Gerasimos, Keren, Andre, Ašanin, Milika, Krljanac, Gordana, Maksimović, Ružica, Skouri, Hadi, Ben Gal, Tuvia, Moura, Brenda, Volterrani, Maurizio, Abdelhamid, Magdy, Lopatin, Yuri, Chioncel, Ovidiu, Coats, Andrew J.S., Seferović, Petar M., Polovina, Marija, Rosano, Giuseppe, Bozkurt, Biykem, Metra, Marco, Heymans, Stephane, Mullens, Wilfried, Bauersachs, Johann, Sliwa, Karen, de Boer, Rudolf A., Farmakis, Dimitrios, Thum, Thomas, Olivotto, Iacopo, Rapezzi, Claudio, Linhart, Aleš, Corrado, Domenico, Tschöpe, Carsten, Milinković, Ivan, Bayes Genis, Antoni, Filippatos, Gerasimos, Keren, Andre, Ašanin, Milika, Krljanac, Gordana, Maksimović, Ružica, Skouri, Hadi, Ben Gal, Tuvia, Moura, Brenda, Volterrani, Maurizio, Abdelhamid, Magdy, Lopatin, Yuri, Chioncel, Ovidiu, and Coats, Andrew J.S.
- Abstract
Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Over the past decades, a progress has occurred in characterization of the genetic background and major pathophysiological mechanisms, which has been incorporated into a more nuanced diagnostic approach and risk stratification. Furthermore, medications targeting core disease processes and/or their downstream adverse effects have been introduced for several cardiomyopathies. Combined with standard care and prevention of sudden cardiac death, these novel and emerging targeted therapies offer a possibility of improving the outcomes in several cardiomyopathies. Therefore, the aim of this document is to summarize practical approaches to the treatment of cardiomyopathies, which includes the evidence-based novel therapeutic concepts and established principles of care, tailored to the individual patient aetiology and clinical presentation of the cardiomyopathy. The scope of the document encompasses contemporary treatment of dilated, hypertrophic, restrictive and arrhythmogenic cardiomyopathy. It was based on an expert consensus reached at the Heart Failure Association online Workshop, held on 18 March 2021.
- Published
- 2023
96. Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
- Author
-
Shahim, Bahira, Shahim, Angiza, Adamo, Marianna, Chioncel, Ovidiu, Benson, Lina, Crespo-Leiro, María Generosa, Anker, Stefan D., Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, McDonagh, Theresa, Mebazaa, Alexandre, Piepoli, Massimo F., Rosano, Giuseppe M.C., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar, Volterrani, Maurizio, Segovia-Cubero, Javier, Amir, Offer, Palic, Benjamin, magg, Aldo P., Metra, Marco, Lund, Lars H., Shahim, Bahira, Shahim, Angiza, Adamo, Marianna, Chioncel, Ovidiu, Benson, Lina, Crespo-Leiro, María Generosa, Anker, Stefan D., Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, McDonagh, Theresa, Mebazaa, Alexandre, Piepoli, Massimo F., Rosano, Giuseppe M.C., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar, Volterrani, Maurizio, Segovia-Cubero, Javier, Amir, Offer, Palic, Benjamin, magg, Aldo P., Metra, Marco, and Lund, Lars H.
- Abstract
[Abstract] Aims: To assess the prevalence, clinical characteristics, and outcomes of patients with heart failure (HF) with or without moderate to severe aortic valve disease (AVD) (aortic stenosis [AS], aortic regurgitation [AR], mixed AVD [MAVD]). Methods and results: Data from the prospective ESC HFA EORP HF Long-Term Registry including both chronic and acute HF were analysed. Of 15 216 patients with HF (62.5% with reduced ejection fraction, HFrEF; 14.0% with mildly reduced ejection fraction, HFmrEF; 23.5% with preserved ejection fraction, HFpEF), 706 patients (4.6%) had AR, 648 (4.3%) AS and 234 (1.5%) MAVD. The prevalence of AS, AR and MAVD was 6%, 8%, and 3% in HFpEF, 6%, 3%, and 2% in HFmrEF and 4%, 3%, and 1% in HFrEF. The strongest associations were observed for age and HFpEF with AS, and for left ventricular end-diastolic diameter with AR. AS (adjusted hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.23-1.67), and MAVD (adjusted HR 1.37, 95% CI 1.07-1.74) but not AR (adjusted HR 1.13, 95% CI 0.96-1.33) were independently associated with the 12-month composite outcome of cardiovascular death and HF hospitalization. The associations between AS and the composite outcome were observed regardless of ejection fraction category. Conclusions: In the ESC HFA EORP HF Long-Term Registry, one in 10 patients with HF had AVD, with AS and MAVD being especially common in HFpEF and AR being similarly distributed across all ejection fraction categories. AS and MAVD, but not AR, were independently associated with increased risk of in-hospital mortality and 12-month composite outcome, regardless of ejection fraction category.
- Published
- 2023
97. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
- Author
-
Kapelios, Chris J., Benson, Lina, Crespo-Leiro, María Generosa, Anker, Stefan, Coats, Andrew J.S., Chioncel, Ovidiu, Filippatos, Gerasimos, Lainscak, Mitja, McDonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo F., Rosano, Giuseppe M.C., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar M., Volterrani, Maurizio, Maggioni, Aldo P., Lund, Lars H., Kapelios, Chris J., Benson, Lina, Crespo-Leiro, María Generosa, Anker, Stefan, Coats, Andrew J.S., Chioncel, Ovidiu, Filippatos, Gerasimos, Lainscak, Mitja, McDonagh, Theresa, Mebazaa, Alexandre, Metra, Marco, Piepoli, Massimo F., Rosano, Giuseppe M.C., Ruschitzka, Frank, Savarese, Gianluigi, Seferovic, Petar M., Volterrani, Maurizio, Maggioni, Aldo P., and Lund, Lars H.
- Published
- 2023
98. Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery
- Author
-
Lund, Lars H; https://orcid.org/0000-0003-1411-4482, Crespo-Leiro, Maria Generosa, Laroche, Cecile, Garcia-Pinilla, Jose M, Bennis, Ahmed, Vataman, Eleonora B, Polovina, Marija, Radovanovic, Slavica, Apostolovic, Svetlana R, Ašanin, Milika, Gackowski, Andrzej, Kaplon-Cieslicka, Agnieszka, Cabac-Pogorevici, Irina, Anker, Stefan D, Chioncel, Ovidiu; https://orcid.org/0000-0002-3197-3628, Coats, Andrew J S; https://orcid.org/0000-0002-2771-4260, Filippatos, Gerasimos; https://orcid.org/0000-0002-5640-0332, Lainscak, Mitja; https://orcid.org/0000-0002-5922-4098, McDonagh, Theresa; https://orcid.org/0000-0003-1305-9602, Mebazaa, Alexandre, Metra, Marco; https://orcid.org/0000-0001-6691-8568, Piepoli, Massimo; https://orcid.org/0000-0003-1124-234X, Rosano, Giuseppe M, Ruschitzka, Frank; https://orcid.org/0000-0001-5972-0596, Savarese, Gianluigi; https://orcid.org/0000-0001-7732-0887, Seferović, Petar M, Iung, Bernard; https://orcid.org/0000-0002-9127-348X, Popescu, Bogdan A; https://orcid.org/0000-0001-6122-8533, Maggioni, Aldo P; https://orcid.org/0000-0003-2764-6779, ESC EORP HF III National Leaders and Investigators, Lund, Lars H; https://orcid.org/0000-0003-1411-4482, Crespo-Leiro, Maria Generosa, Laroche, Cecile, Garcia-Pinilla, Jose M, Bennis, Ahmed, Vataman, Eleonora B, Polovina, Marija, Radovanovic, Slavica, Apostolovic, Svetlana R, Ašanin, Milika, Gackowski, Andrzej, Kaplon-Cieslicka, Agnieszka, Cabac-Pogorevici, Irina, Anker, Stefan D, Chioncel, Ovidiu; https://orcid.org/0000-0002-3197-3628, Coats, Andrew J S; https://orcid.org/0000-0002-2771-4260, Filippatos, Gerasimos; https://orcid.org/0000-0002-5640-0332, Lainscak, Mitja; https://orcid.org/0000-0002-5922-4098, McDonagh, Theresa; https://orcid.org/0000-0003-1305-9602, Mebazaa, Alexandre, Metra, Marco; https://orcid.org/0000-0001-6691-8568, Piepoli, Massimo; https://orcid.org/0000-0003-1124-234X, Rosano, Giuseppe M, Ruschitzka, Frank; https://orcid.org/0000-0001-5972-0596, Savarese, Gianluigi; https://orcid.org/0000-0001-7732-0887, Seferović, Petar M, Iung, Bernard; https://orcid.org/0000-0002-9127-348X, Popescu, Bogdan A; https://orcid.org/0000-0001-6122-8533, Maggioni, Aldo P; https://orcid.org/0000-0003-2764-6779, and ESC EORP HF III National Leaders and Investigators
- Abstract
AIMS Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries. METHODS Between 1 November 2018 and 31 December 2020, 10 162 patients with chronic or acute/worsening HF with reduced, mildly reduced, or preserved ejection fraction were enrolled from 220 centres in 41 European or ESC affiliated countries. The ESC HF III Registry collected data on baseline characteristics (hospital or clinic presentation), hospital course, diagnostic and therapeutic decisions in hospital and at the clinic visit; and on outcomes at 12-month follow-up. These data include demographics, medical history, physical examination, biomarkers and imaging, quality of life, treatments, and interventions - including drug doses and reasons for non-use, and cause-specific outcomes. CONCLUSION The ESC HF III Registry will provide comprehensive and unique insight into contemporary HF characteristics, treatment implementation, and outcomes, and may impact implementation strategies, clinical discovery, trial design, and public policy.
- Published
- 2023
99. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
- Author
-
Kapelios, Chris J; https://orcid.org/0000-0003-1616-6307, Benson, Lina, Crespo-Leiro, Maria G; https://orcid.org/0000-0002-3085-167X, Anker, Stefan D, Coats, Andrew J S; https://orcid.org/0000-0002-2771-4260, Chioncel, Ovidiu, Filippatos, Gerasimos; https://orcid.org/0000-0002-5640-0332, Lainscak, Mitja; https://orcid.org/0000-0002-5922-4098, McDonagh, Theresa; https://orcid.org/0000-0003-1305-9602, Mebazaa, Alexandre; https://orcid.org/0000-0001-8715-7753, Metra, Marco; https://orcid.org/0000-0001-6691-8568, Piepoli, Massimo F; https://orcid.org/0000-0003-1124-234X, Rosano, Giuseppe M C; https://orcid.org/0000-0002-6868-4248, Ruschitzka, Frank; https://orcid.org/0000-0001-5972-0596, Savarese, Gianluigi; https://orcid.org/0000-0001-7732-0887, Seferovic, Petar M; https://orcid.org/0000-0002-1955-4199, Volterrani, Maurizio; https://orcid.org/0000-0002-2624-9213, Maggioni, Aldo P; https://orcid.org/0000-0003-2764-6779, Lund, Lars H; https://orcid.org/0000-0003-1411-4482, Kapelios, Chris J; https://orcid.org/0000-0003-1616-6307, Benson, Lina, Crespo-Leiro, Maria G; https://orcid.org/0000-0002-3085-167X, Anker, Stefan D, Coats, Andrew J S; https://orcid.org/0000-0002-2771-4260, Chioncel, Ovidiu, Filippatos, Gerasimos; https://orcid.org/0000-0002-5640-0332, Lainscak, Mitja; https://orcid.org/0000-0002-5922-4098, McDonagh, Theresa; https://orcid.org/0000-0003-1305-9602, Mebazaa, Alexandre; https://orcid.org/0000-0001-8715-7753, Metra, Marco; https://orcid.org/0000-0001-6691-8568, Piepoli, Massimo F; https://orcid.org/0000-0003-1124-234X, Rosano, Giuseppe M C; https://orcid.org/0000-0002-6868-4248, Ruschitzka, Frank; https://orcid.org/0000-0001-5972-0596, Savarese, Gianluigi; https://orcid.org/0000-0001-7732-0887, Seferovic, Petar M; https://orcid.org/0000-0002-1955-4199, Volterrani, Maurizio; https://orcid.org/0000-0002-2624-9213, Maggioni, Aldo P; https://orcid.org/0000-0003-2764-6779, and Lund, Lars H; https://orcid.org/0000-0003-1411-4482
- Published
- 2023
100. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP:A clinical consensus statement from the Heart Failure Association of the ESC
- Author
-
Bayes-Genis, Antoni, Docherty, Kieran F., Petrie, Mark C., Januzzi, James L., Mueller, Christian, Anderson, Lisa, Bozkurt, Biykem, Butler, Javed, Chioncel, Ovidiu, Cleland, John G.F., Christodorescu, Ruxandra, Del Prato, Stefano, Gustafsson, Finn, Lam, Carolyn S.P., Moura, Brenda, Pop-Busui, Rodica, Seferovic, Petar, Volterrani, Maurizio, Vaduganathan, Muthiah, Metra, Marco, Rosano, Giuseppe, Bayes-Genis, Antoni, Docherty, Kieran F., Petrie, Mark C., Januzzi, James L., Mueller, Christian, Anderson, Lisa, Bozkurt, Biykem, Butler, Javed, Chioncel, Ovidiu, Cleland, John G.F., Christodorescu, Ruxandra, Del Prato, Stefano, Gustafsson, Finn, Lam, Carolyn S.P., Moura, Brenda, Pop-Busui, Rodica, Seferovic, Petar, Volterrani, Maurizio, Vaduganathan, Muthiah, Metra, Marco, and Rosano, Giuseppe
- Abstract
Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. This document from the Heart Failure Association examines the practical uses of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in various clinical scenarios. The concentrations of NT-proBNP vary according to the patient profile and the clinical scenario, therefore values should be interpreted with caution to ensure appropriate diagnosis. Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. We also coin the concept of ‘heart stress’ when NT-proBNP levels are elevated in an asymptomatic patient with risk factors for heart failure (i.e. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. We propose a simple acronym for healthcare professionals and patients, FIND-HF, which serves as a prompt to consider heart failure: Fatigue, Increased water accumulation, Natriuretic peptide testing, and Dyspnoea. Use of this acronym would enable the early diagnosis of heart failure. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs., Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. This document from the Heart Failure Association examines the practical uses of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in various clinical scenarios. The concentrations of NT-proBNP vary according to the patient profile and the clinical scenario, therefore values should be interpreted with caution to ensure appropriate diagnosis. Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. We also coin the concept of ‘heart stress’ when NT-proBNP levels are elevated in an asymptomatic patient with risk factors for heart failure (i.e. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk. We propose a simple acronym for healthcare professionals and patients, FIND-HF, which serves as a prompt to consider heart failure: Fatigue, Increased water accumulation, Natriuretic peptide testing, and Dyspnoea. Use of this acronym would enable the early diagnosis of heart failure. Overall, understanding and utilizing NT-proBNP levels will lead to earlier and more accurate diagnoses of heart failure ultimately improving patient outcomes and reducing healthcare costs.
- Published
- 2023
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.